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Biotextiles are fibrous structures created from synthetic or natural materials, which are 
used as biodegradable temporary scaffolds in tissue engineering. The function of such 
cell-seeded devices is to heal or replace damaged organs or tissues. Biocompatibility and 
retention of mechanical properties in the relatively hostile environment is required from 
the fiber materials. Porosity, pore sizes and pore shapes affect cell coverage and distribu-
tion on the scaffolds. Textile manufacturing techniques provide a vast variety of available 
structures in both small and large scale production. 
The aim of this thesis was to compare cell viability and distribution on textile scaffolds. 
For this purpose melt spinning method was used to process poly-L/D-lactide 96/4 
(PLDLA 96/4) fibers. A 36-week hydrolytic degradation experiment was conducted for 
the gamma irradiated fibers to evaluate retention of mechanical properties and changes in 
crystallinity and thermal properties. Tensile testing method was used for mechanical 
properties and differential scanning calorimetry (DSC) for the two last mentioned.  The 
fibers were used to manufacture braided, knitted and woven fabrics. Heat sealing and 
compression at elevated temperature was used to prepare multi-layered scaffolds with 
approximately 1 mm thickness. Recovery after heat treatment and swelling in cell culture 
medium was evaluated for the scaffolds. Human urothelial cells (hUCs) and human fore-
skin fibroblasts (hFFs) were used in the cell culture experiment. Live/Dead analysis and 
crystal violet staining were used to assess cell viability and distribution. 
Tensile strength of the PLDLA 96/4 fibers decreased during degradation as did strain at 
maximum load. Crystallinity increased with a few percent. Glass transition temperature 
decreased, as was predicted based on previous studies. Unexpectedly, the melting tem-
perature showed a slight increase during degradation. In the recovery and swelling exper-
iments, unwanted changes were not observed. The cell culture experiment demonstrated 
good biocompatibility for the fibers. After 2 weeks of incubation, the less porous braided 
and woven scaffolds had the most attached hUC and hFF cells. The large pores of knitted 
scaffolds remained mostly cell free for both cell types throughout the experiment. 
The experiments conducted for this thesis demonstrated that PLDLA 96/4 fiber bundles 
can be processed into biodegradable braided, knitted and woven textile scaffolds. These 
structures support viability of cells in vitro. The number of attached cells was the largest 
in braided and woven structures that had significantly smaller pores in comparison to 
knitted scaffolds. 
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Kudosteknologian biotekstiilit ovat luonnollisista tai synteettisistä kuiduista valmistettuja 
biohajoavia tukirakenteita eli skaffoldeja. Näitä solujen kanssa implantoitavia rakenteita 
on tarkoitus käyttää kudosten tai kokonaisten elinten korjaamisessa. Kuiduilta vaaditaan 
bioyhteensopivuuden lisäksi mekaanisten ominaisuuksien riittävää säilymistä kehon vaa-
tivissa olosuhteissa. Rakenteen huokoisuus, huokosten koko ja huokosten muoto vaikut-
tavat solujen levittymiseen. Tekstiilien valmistusmenetelmillä voidaan valmistaa moni-
puolisesti erilaisia rakenteita, joiden ominaisuudet vaihtelevat laajalti. 
Diplomityön tavoitteena oli vertailla solujen elinkykyisyyttä ja levittäytymistä tekstiili-
skaffoldeilla. Tätä varten poly-L/D-laktidi 96/4:stä (PLDLA 96/4) valmistettiin kuitufi-
lamentteja sulakehruu-menetelmällä. Muutoksia gammasäteilyllä steriloitujen kuitujen 
mekaanisissa ominaisuuksissa, kiteisyydessä ja termisissä ominaisuuksissa hydrolyytti-
sen hajoamisen aikana seurattiin 36-viikkoisella kokeella. Kuiduista valmistettiin punot-
tuja, neulottuja ja kudottuja tekstiilejä, joita käytettiin 1 mm paksuisten skaffoldien val-
mistuksessa. Rakenteiden mittapysyvyyttä lämpökäsittelyn jälkeen ja ravinnenesteen 
upotettuna seurattiin kahden viikon kestoisten kokeiden avulla. Soluviljelykokeissa käy-
tettiin ihmisen uroteelisoluja (hUCs) ja ihmisen esinahan fibroblasteja (hFFs). Live/Dead-
analyysia ja kristallivioletti-värjäystä käytettiin elinvoimaisuuden ja levittäytymisen ar-
vioimisessa. 
PLDLA 96/4 kuitujen vetolujuus ja myötymä suurimman rasituksen aikana laskivat ha-
joamisen seurauksena. Kiteisyys kasvoi muutamalla prosentilla. Kuten aikaisempien tut-
kimusten perusteella oli odotettua, lasisiirtymä-lämpötila laski hajoamisen seurauksena. 
Sulamislämpötilan lievä kasvu ei vastannut aikaisempien kokeiden tuloksia. Palautumis- 
ja turvotuskokeissa havaitut mittamuutokset eivät olleet merkittäviä. Soluviljelykoe 
osoitti polylaktidi-kuitujen olevan bioyhteensopivia molempien solutyyppien kanssa. 
Kahden viikon inkuboinnin jälkeen punotuilla ja kudotuilla skaffoldeilla oli eniten soluja 
kiinnittyneenä. Erityisesti fibroblastit suosivat kuoppia harjanteiden sijaan rakenteissa. 
Neulosten suuret huokoset pysyivät lähes kokonaan soluttomina koko viljelyjakson ajan. 
Kokeet osoittivat PLDLA 96/4 kuitukimppujen soveltuvan biohajoavien punottujen, neu-
lottujen ja kudottujen skaffoldien valmistukseen. Skaffoldit tukevat hUC- ja hFF-solujen 
kasvua in vitro. Suurimmat solumäärät havaittiin punotuissa ja kudotuissa skaffoldeissa, 
joissa huokosten koko oli selvästi neuloksia pienempi. 
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1. INTRODUCTION 
Biotextiles are described as non-viable, permanent or temporary, fibrous textile structures 
created from synthetic or natural materials, which are used as medical devices inside or 
outside the body. The function of such textiles is to improve the health, medical condition, 
comfort and wellness of the patient by prevention, treatment or diagnosis of an injury or 
disease. In addition, biotextiles are in contact with circulating blood or body fluids. There-
fore, they need to function in a relatively hostile biological environment. This distin-
guishes biotextiles from most other medical textiles. [1] When a biotextile is seeded with 
living cells, it is considered a tissue engineering (TE) construct. For these constructs, it is 
often desirable to use biodegradable polymers [1] that are replaced over time with regen-
erating native tissue when implanted [1; 2].  
Implantable textile structures are routinely used in surgery to direct, supplement or re-
place the functions of living tissues. Examples include sutures, vascular grafts, ligament 
and tendon prostheses, heart valves and joint replacements. Using biomaterials alone can 
be successful, but infection, failure and rejection of implants remains an issue. The field 
of tissue engineering challenges this issue by combining biomaterials and mammalian 
cells to create living synthetic tissue constructs [3] to increase the biocompatibility of the 
implants. 
Woven, knitted, braided and embroidered fabrics are usually made from filament or staple 
fiber yarns and non-wovens from the fibers or directly from a polymer. The properties of 
the fabrics depend on the properties of the yarns or fibers and the geometry of the struc-
ture, for non-wovens also on binder properties and bonding method. [4] Because there 
are numerous combinations of different materials and structures, the properties of the 
fabrics vary on a broad range. Therefore, it is possible to design textiles that mimic struc-
tural and mechanical properties of various biological tissues. [5] To enhance chemical 
compatibility, the fibers or textile structures may also be surface modified to improve 
host-biomaterial interactions. [6] Mechanical properties of textiles are usually aniso-
tropic, with exception of some non-wovens. Characteristic properties include high in-
plane stiffness and low bending resistance. [5] To meet the requirements of different ap-
plications, the required characteristics need to be understood and the parameters influenc-
ing the performance must be known. Traditional textile forming methods such as braid-
ing, knitting and weaving allow production of structures with minimal batch-to-batch var-
iation even at large scale production. This makes textiles an interesting group of materials, 
when considering commercializing a product. 
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In this work, textile scaffolds were manufactured from melt spun poly(LD-lactide) 96/4 
(PLDLA 96/4) fibers using three different methods: (i) braiding, (ii) knitting and (iii) 
weaving. Changes in mechanical and thermal properties during hydrolytic degradation of 
the fibers were assessed using tensile testing and differential scanning calorimetry (DSC) 
tests. Cell viability and distribution on these structures was studied using human foreskin 
fibroblasts (hFF) and human urothelial cells (hUC) with live/dead analysis and crystal 
violet staining. The aim was to compare the distribution of cells between the three textile 
types used in the scaffolds. The scaffolds varied in pore sizes and in fiber arrangement. 
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THEORETICAL BACKGROUND 
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2. TEXTILES IN TISSUE ENGINEERING 
Based on 188 research articles [Appendix A] with full online access from Tampere Uni-
versity of Technology (TUT), cell growth in braided, embroidered, knitted, woven and 
non-woven textile structures has been a subject of interest for past 20 years. The data 
includes research articles where cell growth on textile structures has been studied in vitro, 
in vivo or both. However, in some references that is not the main topic of the research. 
Electrospinning as a method is excluded from the non-wovens, but it should be noted that 
during this research, more electrospinning articles in the field of tissue engineering were 
found than for the other textile methods combined. The exclusion was because of practical 
reasons, to decrease the number of articles to process. In addition, not all electrospun 
structures can be considered to be non-woven textiles. The thesis focuses on more tradi-
tional textiles. Figure 1 presents the number of articles released in five-year periods since 
the year 1996. The most articles per year were published in the years 2010, 2006 and 2005 
with 22, 20 and 19 articles. It is necessary to speculate here, that limited access to recently 
released articles probably decreases the amount of articles included here from last few 
years. The same may apply as well to older articles initially not published online. This 
should be considered when inspecting chart in Figure 1. 
 
Figure 1.  Number of research articles published during time period. [Appendix A]. 
In most of the research articles in Figure 1, only one type of textile structure was used. 7 
articles describe use the of two types of textiles [7-13]. Ramakrishna mentioned in 2001 
investigating hepatocyte attachment on braided, knitted and woven fabrics in their pre-
liminary research [3], but a comprehensive comparative research of cell growth on textile 
structures manufactured with several different methods is still to be conducted. 
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2.1 Tissue engineering 
To find a solution to chronic donor organ shortage, tissue engineering constructs are being 
researched. TE has been described as a field of research where artificial tissue and organs 
are fabricated, but this description is too broad. TE constructs differ from artificial organs 
such as mechanical hearts by combining living cells and biomaterials to mimic mamma-
lian extracellular matrix (ECM). [14] Besides treating human patients, the constructs 
could also be used to replace animal models in research areas such as drug development. 
2.2 Structures 
According to the same 188 articles in Appendix A mentioned earlier, non-wovens, fol-
lowed by the knits and braids, are the most researched textile structures in tissue engi-
neering (Figure 2) in respect of cell growth. Using non-wovens is attractive for research 
because manufacturing scaffolds does not necessarily require expensive and complicated 
machinery. Having a mould, fibers and a binder [15] or only a bundle of fibers arranged 
by hand [16] can be sufficient depending on the purpose. Therefore, for example new 
materials, coatings, treatments and different cell types, and their combinations can be 
investigated with smaller investments. On the other hand, if considering production on 
larger scale, the orientation and density of the fibers is more difficult to control in non-
wovens in comparison to the other methods such as braiding, knitting or weaving. This 
means also less control over pore sizes and shapes. 
 
Figure 2.  The most used manufacturing techniques for textiles in TE. [Appendix A] 
The suitable type of textile structure for an application is often determined by the require-
ments set by the intended application. For example, knits and braids may be more suitable 
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for applications requiring high tensile strength such as regeneration of tendons or liga-
ments. On the other hand, non-woven meshes with low mechanical strength may be suit-
able to fill soft tissue or low load bearing cartilage and bone defects. Different textiles 
can also be used to produce hybrid structures such as presented in articles from Hegewald 
et al. [10], Farè et al. [9] and Iwai et al. [8], which all have layers manufactured with 
different techniques. 
2.2.1 Non-woven 
Non-woven fabrics are made by entangling loose fibers or directly from polymers. En-
tangling methods include carding, hydroentangling, needle-felting, chemical bonding and 
thermal bonding. Entangled fibers may be in either staple or continuous form. Manufac-
turing directly from polymers usually takes place by melt blowing, spun bonding or elec-
trospinning. [4; 17] Figure 3 presents an example of a needle-felted scaffold that was 
manufactured from melt spun poly(ester amide) (PEA) fibers to investigate the suitability 
of the material for tissue engineering applications [18]. 
 
Figure 3. Needle-felted non-woven PEA scaffolds. Modified from [18]. 
The properties of non-woven fabrics depend on the fibers, arrangement of the fibers and 
bonding method. From tissue engineering aspect, micro- and nanofiber non-woven scaf-
folds are nearly ideal for growing tissues due to their resemblance to native ECM, high 
surface-to-volume ratio and highly porous interconnected pore network, all important for 
cell attachment and proliferation. [4] As disadvantages, non-wovens often do not recover 
after extension [4] and the scaffolds structure can be difficult to control and reproduce 
accurately on microscopic level in the manufacturing process. 
2.2.2 Knitted 
Knitting is a technique where continuous series of loops of yarns are intermeshed using 
hooks or needles. A needle or hook is used to catch a yarn and to draw it through a pre-
viously formed loop to create a new loop. Knitted fabrics are categorized as weft or warp 
knits. In the first-mentioned, loops are formed transversely and in the latter vertically, 
into rows and columns respectively (Figure 4). A warp knitting machine uses a running 
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sheet of yarns, similar to a weaving loom. In comparison, weft knits can be produced 
faster, more economically and can be accomplished with a single spool of yarn. [4]  
 
Figure 4. Schematic illustrations of the structures of weft-knitted fabric (left)  
and warp-knitted fabric (right). Modified from [19, p. 70]. 
Knits as a class are more flexible, compliant and conformable than for example woven 
fabrics. The simplest weft knits are very extensible and dimensionally unstable, but these 
properties can be improved by adding yarns into the knit to interlock the loops. Warp 
knits in general are more interlocked, dimensionally stable and do not unravel as easily 
when cut. [4] The pore size of the fabric can be adjusted by changing the loop size, yarn 
diameter and filament count of the yarn, but it still tends to be higher than in other types 
of fabrics. 
2.2.3 Braided 
Braids are manufactured by crossing at least three yarns diagonally, so that the yarns are 
alternating over and under each other (Figure 5). The method is similar to weaving, except 
the yarns are in different angles. Braided structures may be flat, tubular or tubular with a 
core. As the yarns are taken from individual spools, it is possible to use a variety of dif-
ferent yarns simultaneously in a braid. For the core, any solid material with high length 
to diameter ratio may be used as long as its diameter does not exceed limits set by the 
machinery. For example, different yarns, tubes or rods of can be used. Tubular braids are 
produced by braiding over a mandrel, which is later removed. [4] 
8 
 
Figure 5.  1/1 braided structure (left) and 2/2 braided structure (right). X = number 
of yarns fed simultaneously.  
Pick spacing, braid angle and the constituent yarns determine the mechanical properties 
and porosity of the braids. The tensile behavior of common biaxial braids can be divided 
into two steps as shown in Figure 6. Under tensile load in the first step the yarns slide 
against each other until maximum geometrical deformation is reached. During elongation, 
the braid angle decreases as the yarns position more towards the direction of braid axis. 
In the second step, tensile behavior depends on the tensile properties of the yarns. In this 
case, the Young’s modulus (E) is lower in the first step. [4; 20] This simplified two-step 
behavior does not always apply to braids that have initially yarns in the braid axis direc-
tion, such as some triaxial braids or braids with a core yarn. In such cases, the modulus 
of the additional yarns can be higher than the braid would otherwise have in step 1, which 
results the yarn being the dominant factor when tensile stress is first applied. Like wovens 
and weft-knits, braids tend to unravel when cut. 
 
Figure 6.  Behavior of a braid under tensile stress. ϴ=braid angle, X=pick spacing 
and A=braid axis. Modified from [20]. 
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Most common use of braids in clinical applications is as sutures. While in tissue engi-
neering porosity is required property from implantable structures, in case of sutures it is 
seen as an increased risk to harbor contaminants. [4] Due to highly tailorable tensile 
strength and pore size, braids are of especially interesting structures for ligament and ten-
don tissue engineering. [21] 
2.2.4 Woven 
Woven fabrics are made on a loom where cross-threads, called the weft, are inserted to 
interlace with a transverse sheet of yarns called the warp. The simplest biaxial woven 
structure is known as a plain weave. It has the weft yarns alternating over and under the 
warp yarns as shown in Figure 7. [4] Hundreds of biaxial structures with different inter-
lacings can be manufactured depending on the properties of the loom in use. The biaxial 
woven fabrics where the warp and the weft are perpendicular to each other are the most 
common, but multiaxis weaves and three-dimensional structures are also possible to man-
ufacture. [22] 
 
Figure 7. Schematic illustration of the structure of a plain weave fabric. 
Biaxial woven fabrics are considered to be dimensionally stable and to have low extensi-
bility, though this can be modified to some extent by incorporating elastomeric yarns. By 
controlling warp and weft density, yarn diameter and yarn type, fabric porosity can vary 
from zero to a high value. [4] Warp and weft densities are affected by the type of yarns 
used and the pressure applied by the beater. Affecting yarn properties include cross-sec-
tional diameter, filament count and stiffness. A concern with woven fabrics is that they 
tend to unravel at the edges when cut [4]. There are methods, such as sewing or melting 
the edges, to avoid this behavior. 
2.2.5 Embroidered 
Embroidery is a method where yarn is stitched onto a base fabric with a needle in a con-
trolled process. The base fabric may or may not be removed after stitching. Advantages 
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of embroideries are high variability in possible designs and controlled adjustment of me-
chanical properties to meet the requirements of the application. With electronically con-
trolled machinery, computer assisted designs (CAD) can be manufactured (Figure 8). The 
method allows rapid prototyping of laboratory samples for research in small scale with 
minimal material usage. In addition, it is easy to upscale the process to large scale pro-
duction if desired. [5; 23; 24] Example of an embroidered implant is presented in Figure 
8, which shows a poly(caprolactone-co-lactide) (P(LA-CL)) scaffold designed for calvar-
ial bone defect treatment in rabbits by Rentsch, C. et al. The CAD-design was embroi-
dered on a water-soluble polyvinyl alcohol (PVA) base fabric, which was later removed. 
The scaffold consists of two parts that were sewn together after embroidery. [25] 
 
Figure 8.  Embroidered P(LA-CL) scaffold [25]. 
Unlike braided, knitted and woven fabrics, embroidered fabrics do not necessarily consist 
of repeated units or have a defined fabric formation direction. The yarns can be arranged 
in any direction on a flat surface and even rounded patterns can be created. Adding yarns 
on the top of each other results in a three-dimensional structure. The smallest structural 
unit in embroidered textiles is a stitch. These stitches can vary in length, density, direction 
and type of locking. If desired, groups of periodically arranged stitches can form a re-
peated pattern. By utilizing the color change feature on embroidery machines, several 
types of yarns can be used simultaneously. This allows, for example, reinforcing the em-
broideries with high tensile strength yarns or using both multi- and monofilament yarns 
with variable cross-sectional diameters. These freedoms in design allow the manufactur-
ing of textiles with well-controlled properties mimicking the anisotropic properties of 
mammalian tissues. [5; 24] 
2.3 Fiber materials 
The 188 research articles in Appendix A describe the use of 33 different fiber materials 
for manufacturing textile structures. Five most commonly used materials are presented in 
Figure 9. From these materials silk stands out as the only natural polymer, while the others 
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are synthetic or natural derived. Interestingly, one of the materials, poly(lactide-co-gly-
colide) (PLGA), is a copolymer of two other materials polyglycolide (PGA) and polylac-
tide (PLA). This increases the significance of PGA and PLA as fiber materials. All five 
materials are biodegradable polymers with a wide range of degradation rates varying from 
months to years. [26; 27] A list consisting all of the 33 fiber materials used can be found 
in Appendix B. The wide range of materials shows how versatile selection of materials is 
available to be processed into biotextiles. For example, some less expected material se-
lections include bioglass [28], carbon nanotubes [29] and titanium [30]. In principle, an-
ything solid with a high length to thickness ratio can be used as the weft of woven fabrics 
or arranged into non-woven structures. For braiding, embroidery and knitting, in general, 
more strict restrictions apply. 
 
 
Figure 9. The most used fiber materials for TE textiles [Appendix A]. 
All fiber materials used in textile based TE constructs need to be biocompatible with the 
host tissue and need to have sufficient properties to be processed into yarns and fabrics. 
In addition, bioactivity is also often desired for the implant to perform as desired. There 
are several physical fiber attributes to consider: size and shape, tensile properties, bending 
properties, thermal properties, surface energetics and moisture properties. [4] Biocompat-
ibility and bioactivity are discussed in more detail in subsection 2.4.1 on page 18. 
For tissue engineering purpose, a small fiber diameter is usually considered an advantage, 
but at the same time, the processing of very thin fibers into textiles may be more chal-
lenging. Stiffness is important for both processing and application. During processing, 
the yarns must bend into desired forms such as loops in knits. In implants, flexibility can 
be crucial for conformability and intimacy of contact. Thermal properties affect especially 
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processing, but also for the stability of material when in use. For cells to successfully 
attach and proliferate on biomaterial surface, the surfaces must be wetted. Therefore, it is 
an advantage for the biomaterial to be hydrophilic, which results in spreading of aqueous 
fluids on the surface instead of beading. [4] For hydrolytically degrading biomaterials, 
reaction to aqueous fluids is an important factor, because it affects the degradation kinet-
ics. 
2.3.1 PGA 
Polyglycolide, a thermoplastic linear aliphatic poly(α-ester), was used as a biodegradable 
Dexon® suture as early as 1969. Since then it has been used in tissue engineering scaffolds 
because of its degradation properties, mechanical properties and cell viability on the scaf-
folds. PGA is hydrophilic and 45–55 % crystalline. Because of its highly crystalline struc-
ture, it has excellent mechanical properties and low solubility in organic solvents. [26] 
The glass transition temperature ranges between 35–40 ºC and melting temperature from 
220 ºC to 230 ºC. Due to its fiber forming capability by melt extrusion, it is suitable for 
textiles. The fibers are stiff, but can be processed into yarns. The stiffness can be reduced 
by copolymerizing glycolide monomers with other monomers such as ε-caprolactone. 
[26; 31] PGA has been shown to have elastic modulus from 7.0 GPa to 12.5 GPa, elon-
gation of 15–30 % at break and high tensile strength of 890 MPa at break [31-33]. 
High molecular weight (Mw) PGA is synthesized via catalyzed ring-opening polymeriza-
tion of cyclic diesters of glycolide as shown in Figure 10 below. The process yields ma-
terial with high Mw polymer chains and 1–3 % of residual monomers. [31] It is possible 
to synthesize low Mw PGA via condensation method, but the obtained brittle polymer 
cannot be processed into fibers. [34] 
 
Figure 10. Polyglycolide synthesis from glycolide monomer via ring-opening 
polymerization. Modified from [31; 35]. 
PGA degrades through hydrolysis where water molecules break the ester bonds in the 
polymer backbone. Because of hydrophilicity of the material, it undergoes bulk degrada-
tion. The polymer loses its strength, often suddenly, in 1–2 months and loses its mass in 
6–12 months. The polymer degrades into glycolide, which at high concentration may 
lower the pH of the tissue and cause inflammation. Glycolide is further broken down into 
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glycine to be either excreted into urine or to be converted into CO2 and H2O in the citric 
acid cycle. [32] The acidic degradation products and high degradation rate may be con-
sidered as disadvantages in tissue engineering applications. [26] 
2.3.2 PLA 
Similarly to PGA, polylactide (PLA) is also a thermoplastic linear aliphatic poly(α-ester) 
that undergoes hydrolytical biodegradation. The two polymers are structurally similar, 
differing in addition of pendant methyl group in PLA. The group lowers the melting tem-
perature (Tm), increases hydrophobicity and decreases degradation rate by reducing the 
ester bond scission. Lactic acid or 2-hydroxypropionic acid monomers exist in two iso-
meric forms, L- and D-lactic acid, making it a chiral molecule. Only L-lactic acid occurs 
in nature, in mammals specifically. Polymerization of either one alone results in semi-
crystalline polymers. [26; 31; 36] However, the polymerization of a mixture of these two 
monomers leads to formation of amorphous polymers if the polymer contains more than 
approximately 15 % of the D-isomer [37]. The glass transition temperature (Tg) of PLLA 
and PDLA is at 55–65 ºC and Tm around 180 ºC.  PLLA is approximately 37 % crystalline, 
depending on the polymers Mw and processing conditions. It has good tensile strength of 
30–70 MPa at break, high modulus of 4.8 GPa and low elongation of 6–18 % at break. 
[26; 33; 36] Poly(LD-lactide) (PLDLA) is amorphous, as stated above, and has Tg of 55–
60 ºC. It has lower modulus than PLLA, around 1.9 GPa. [26] 
Synthesis of PLA is also similar to the synthesis of PGA. It is possible to synthesize PLA 
directly from L- and D-lactid acid monomers via polycondensation method, but the pro-
duced polymer has low Mw and poor mechanical properties. The preferred method is to 
first produce cyclic dimers, lactides, from which PLA is synthesized using ring opening 
polymerization (Figure 11). Because lactid acids exist in two stereoisomeric forms, the 
lacide dimers can be arranged into three different dimers: L,L-lactide, D,D-lactide or L,D-
lactide. [38] 
 
Figure 11. Polylactide synthesis via ring opening polymerization [38]. 
PLA undergoes hydrolytic bulk degradation. Scission takes place at the ester groups of 
the polymer backbone breaking the polymer chain eventually into lactic acid, which is 
metabolically converted to water and carbon dioxide. Hydrolysis of PLA is autocatalysed 
by increased presence of carboxylic chain ends. The degradation rate is affected by such 
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factors as molar weight and distribution, swelling of the matrix, morphology, stereochem-
istry, crystallinity and chain mobility. In semi-crystalline structure, hydrolysis preferably 
takes place at the less densely packed amorphous region as the structure is easier for water 
to penetrate. For this reason, amorphous PLDLA degrades at higher rate than crystalline 
PLLA, which is reported not being completely resorbed in vivo even after 5.7 years. 
PLDLA experiences loss of strength in 1–2 months and loss of mass in 6–12 months. 
During hydrolysis molecular weight and distribution, surface morpohology, mechanical 
properties, crystallinity and other properties are affected. [31; 32; 38; 39]  
2.3.3 PLGA 
Poly(lactide-co-glycolide) (PLGA) is copolymerized from glycolic acid and L- or DL-
lactic acid to tailor material properties of either constituent polymer. High Mw PLGA can 
be obtained via ring-opening polymerization method as presented in Figure 12. Copoly-
mers in wide range of monomer ratios have been researched for controlled drug release 
applications and medical devices such as sutures and tissue engineering scaffolds. [31; 
40] 
 
Figure 12. PLGA copolymer synthesis. Modified from [31; 35]. 
Because PLA and PGA have different susceptibility to hydrolysis, the degradation rate of 
PLGA can be modified by adjusting the copolymer ratio. This property makes it an ap-
propriate biomaterial for temporary medical applications. The dependence is not linear as 
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can be seen in Figure 13. The highest degradation rate of 1–2 months is achieved with 
50:50 copolymer ratio. Slower rates have been attained with 75:25 and 85:15 ratios, 4–5 
months and 5–6 months respectively. [31; 40] PLGAs with higher lactic acid content are 
more hydrophobic, which leads to longer degradation time [41]. In addition to copolymer 
ratio, the degradation rate is affected by multiple factors including molecular weight and 
size and shape of the object. The degradation method of PLGA is bulk erosion via hy-
drolysis of the ester bonds. [26] Similarly to the homopolymers PLA and PGA, the deg-
radation products of PLGA are metabolized by the body. 
 
 
Figure 13. Half-life of PLLA and PGA homo- and copolymers in vivo [31; 42]. 
As PLA and PGA independently, PLGA is also a thermoplastic polyester. Depending on 
the polymer ratio, it exists in both amorphous and semi-crystalline forms. When the L-
lactide is used, having 25–70 % glycolide results in amorphous structure. With DL-lac-
tide, 0–70 % of glycolide elicits the same result. [31; 40] The Tg of PLGA is generally 
considered to be higher than 37 ºC, but it has been experimentally shown to vary in the 
range of 28–49 ºC [43]. The Tm for semicrystalline PLGA is in the range of approximately 
120–220 ºC [44]. The elastic modulus of PLGA is around 2 GPa and elongation from 3 % 
to 10 % [33; 35].  
2.3.4 PCL 
Poly(ε-caprolactone) or polycaprolactone (PCL) is a semicrystalline linear aliphatic pol-
yester consisting of five methylene groups linked by an ester group as shown in Figure 
14. It has low tensile strength of 5-29 MPa and elastic modulus of 0.4 GPa, however the 
elongation at break is high, 300–800 %. [26; 33; 40]. PCL has low melting point of 55–
60º C and glass transition temperature of -60 ºC. This in combination with good solubility 
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in many organic solvents and the ability to form miscible blends with a wide range of 
polymers, makes PCL highly processible. [26] Copolymerization and blending can be 
used to tailor the mechanical and degradation properties of the polymer.  
High Mw PCL is obtained by the alcohol initiated ring-opening polymerization of ε-ca-
prolactone as presented in Figure 14. Other methods, such as ROP of 2-methylene-1,3-
dioxepane has been investigated, but the first mentioned remains the most significant 
method. [26; 40] As a result of polymerization, a hydrolysable ester linkage is formed 
[36]. 
 
Figure 14. Ring-opening polymerization of PCL. Modified from [40]. 
PCL degrades by bulk or surface hydrolysis of ester linkages in the polymer backbone. 
Due to hydrophobicity and crystallinity, it takes PCL from 2 to 4 years to degrade. The 
rate can be increased by copolymerizing PCL with for example PGA or PLA. [36; 45] 
The degradation product, caproic acid is metabolized via the citric acid cycle [36; 40; 45]. 
Long degradation time, drug permeability and biocompatibility make PCL a suitable ma-
trix material for long-term drug and vaccine delivery devices. [26] 
2.3.5 Silk 
Silks are classified as natural protein based polymers. The two main sources for silk are 
spiders and silkworms. The attractiveness of silks for TE comes from its good mechanical 
properties and biocompatibility. Silk fibers have high elasticity and tensile strength. [36; 
46] The elastic modulus is found to be in the range of 5–17 GPa, ultimate tensile strength 
at 500–972 MPa and strain at break at 4–20 % [46]. To enhance biocompatibility, modi-
fication of the fibers is sometimes necessary. For example, the glue-like sericin protein 
coating is often removed from silkworm silk fibers. The primary structure of silk is a 
repeated sequence of proteins whose molecular weight is approximately 25 000–
500 000 g/mol. The high mechanical strength comes from the secondary structure, ori-
ented β-sheet crystals within the fibers. The fibers are connected with hydrogen bonds. 
Chemical structure of silk protein chain is shown in Figure 15. Silks are glycine rich. The 
second and third most common amino acids in the sequence are serine and alanine, but 
many others exist as well. [36; 46] 
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Figure 15. Chemical structure of silk. Modified from [47]. 
Silk degrades slowly proteolytically by proteases such as chymotrypsin. In vitro studies 
have shown the scission to take place at the less-crystalline regions of the proteins, result-
ing in smaller peptides that can be phagocytosed and metabolized. In vivo, the fibers lose 
their tensile strength in approximately 1 year and degrade beyond recognition within 2 
years. The degradation rate depends on implantation site, mechanical forces, type of silk 
and cross-sectional diameter of the fiber. [46] 
2.4 Preclinical studies 
Before a tissue engineering construct can enter clinical trials on humans, it has to go 
through rigorous preclinical research to ensure patient safety and to demonstrate efficacy 
of the design. In the first stage, materials are characterized for adequate attributes such as 
mechanical properties, degradation behavior, effect of sterilization and biocompatibility. 
This is mostly done in vitro, but also ex vivo when possible. If the material does not pass 
the first stage, it does not enter the second stage of investigation. The second stage con-
sists of in vivo biocompatibility and performance studies in animal models. [48] Initially 
small animal models are used to study tissue-biomaterial interactions in non-functional 
conditions. If successful, experiments succeed with functional tests in larger animal mod-
els more similar to humans. [48; 49] Data obtained from 188 published research articles 
in Appendix A, shows that most of these studies include in vitro methods as shown in 
Figure 16. Also worth noticing is the complete absence of ex vivo experiments. The types 
of cells and animals used in these studies are discussed in more detail in subsection 2.4.2, 
along with cell culturing conditions. 
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Figure 16. In vivo and in vitro methods used with biotextiles in TE research 
[Appendix A]. 
Main advantages for using in vitro methods over in vivo for biocompatibility screening 
are reasonable cost, requirements for facilities and equipment, processing time for multi-
ple material candidates and absence of live animals. Still, in vivo studies in suitable animal 
models are necessary before an implantable tissue engineering construct can be consid-
ered for clinical trials. Testing on different species means that the results from animal 
models are not directly comparable to humans. Therefore choosing an appropriate animal 
is very important. The need for use of animal models must be thoroughly considered and 
if used, planned responsibly to avoid unnecessary animal experimentation. [48] 
2.4.1 Biocompatibility 
Biological and synthetic materials have some very different characteristic properties. For 
example, tissues contain cells and are able to regenerate or heal. [48] Tissue engineering 
constructs aim to diminish these differences. To achieve this, biomaterials used in these 
constructs must be compatible with the host tissue. 
When a foreign body is inserted into the human body, complex defense mechanisms are 
activated. This is how the body protects itself from numerous threats. Implanted bio-
materials and tissue engineering constructs must be designed to be accepted by the im-
mune system. In case of biodegradable materials, also the degradation products must be 
considered. Otherwise, the implants are treated as threats and will not be able to fulfil 
their therapeutic purposes. This acceptance of foreign bodies by the host is referred to as 
biocompatibility. [14]  
Biocompatibility can be tested by simulating the host environment in several stages. At 
first the material is tested in vitro with live cells and tissues, then ex vivo if possible, 
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followed by animal models before clinical trials on humans. [48] Evaluation is performed 
in this order because of ethical, financial and practical reasons. 
Bioactivity describes an interaction between a biomaterial and the surrounding tissue that 
elicits a specific response. The activity can be based on either biological recognition or 
material transformation. In the first-mentioned, the biomaterial may be incorporated for 
example with growth factors to transfer information from the biomaterial to the surround-
ing cells. In the latter, a material transforms from one state or shape to another when 
introduced to the host tissue as a reaction to for example temperature or pH level. Trans-
formations can be utilized to release substances such as growth factors or antibiotics. Bi-
oactivity can be used for many purposes, including promoting of cell adhesion and pro-
liferation, enhancing vascularization and preventing blood coagulation or infection. [50] 
2.4.2 Cell cultures and animal models 
Based on research articles in Appendix A, most common cells grown on biotextiles in 
vitro can be grouped under differentiated cells. In addition, numerous studies have been 
conducted using stem cells and a few studies using tumor cells. Both animal and human 
cells have been widely used, as both are relatively easy to obtain. Most cells in these 
studies were studied in vitro, but some were implanted with a scaffold into an animal 
model. In some experiments, the cells were grown on the scaffolds in vitro before im-
plantation. Visual presentation of these statistics is presented in Figure 17. When viewing 
the chart, it should be taken into account that one research article may contribute to more 
than one category. 
 
Figure 17. Cell types (left) and cell sources (right) used with biotextiles in TE 
research. [Appendix A] 
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50 studies in Appendix A that used differentiated cells used fibroblasts. The next most 
common cell type, used in 22 studies, were cartilage cells such as chondrocytes, temporo-
mandibular joint disc cells and annulus fibrosus cells. Endothelial cells and ligament or 
tendon cells were used in 14 and 10 studies respectively. Other differentiated cell types 
were used by less than 10 studies. Mesenchymal stem cells (MSCs) were the most com-
mon stem cell type used. Embryonic stem cells (ESCs) and induced pluripotent stem cells 
(iPSCs) were used in only 2 studies. From the MSCs bone marrow stem cells (BMSCs) 
were used in 43 studies making them stand out as the most commonly used type of stem 
cells. BMSCs were followed by adipose stem cells with 7 studies, neural stem cells with 
2 and amniotic fluid stem cells with 1 study. The few tumor cells that were used in ex-
periments were astrocytomas, neuroblastomas, carcinoma cells and melanoma cells.  
The selection of a cell type is based on intended application, availability, cost and purpose 
of the study. For example, if the goal of the study is to investigate biocompatibility of a 
material without any specific application in mind, possibly the most affordable and easily 
obtained cells can be used. In general, different cell types and sources are used as pre-
sented in Figure 18. Commercial cell lines are suitable for the initial stages of research 
because they are relatively inexpensive, easy to culture and have reproducible pheno-
types. Later, isolated animal cells are used in small and large animal studies. Before clin-
ical trials, human primary cells are used with large animal models. In clinical trials on 
humans, only autologous cells are used. Use of stem cells, often BMSCs, is common. [14] 
Figure 18 shows changes in cell sourcing as tissue engineering research progresses. 
 
Figure 18. Cell sourcing in tissue engineering research [14, p. 55]. 
Cells are cultured in vitro in static, dynamic or bioreactor conditions. Static condition is 
the most straightforward and the most common method (Figure 19) where the cells are 
not conditioned to any added stimulation. The definitions of dynamic and bioreactor cell 
culturing conditions are partially intersecting. Sometimes all dynamic culturing condi-
tions are referred to as bioreactors, but to differentiate the more complex setups from the 
less complex they are treated separately here. In dynamic conditions, flow of culture me-
dium is added to the system using devices such as spinner flasks [51; 52] or roller bottles. 
With bioreactors, in vivo conditions are simulated during in vitro cell culturing, flow of 
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culture medium being one of the possible controlled parameters. Other common parame-
ters are for example mechanical stimulus, pH and nutrient levels. In tissue engineering, 
bioreactors are often custom built or customizable systems for cell culturing and prolif-
eration and for providing controllable and stabile physiological conditions for artificial 
tissue formation, development and maturation. [14] 
 
Figure 19. Cell culturing conditions used with biotextiles in TE research [Ap-
pendix A]. 
Different animal models used in research articles of Appendix A are presented in Figure 
20. The data supports the progress from small animal models to large animal models in 
tissue engineering research shown previously in Figure 18. Total of 48 research articles 
describe the use of small animal models and 17 articles of large animals. Worth noticing 
is the absence of primates, the anatomically and physiologically closest animal models to 
humans. Working with primates is a rare privilege for researchers. 
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Figure 20. Different animal models used with biotextiles in TE research [Ap-
pendix A]. 
The path from preclinical studies to clinical trials is complex. It involves an enormous 
amount of choices to be made with materials, equipment, animals and methods used both 
in in vitro and in vivo. In addition, there is ethical factors to consider as well when working 
with animal models. Detailed planning and constant evaluation of progress are necessities 
for a tissue engineering research project to be successful. [53] 
2.5 Clinical applications 
When looking at data collected from 188 published research articles in Appendix A, it is 
apparent that textiles have been most researched for applications requiring good mechan-
ical properties (Figure 21). Artificial tendons and ligaments are subjected to tensile stress, 
bones to compression and cartilage to shear and compression. For each application, the 
types of textiles used in the research are also shown in Figure 21. The data contains ex-
periments from different stages of research, both in vitro and in vivo. This explains why 
20 articles mention using non-wovens in research for tendon or ligament applications that 
require high tensile strength. For example, the non-wovens may have been used for early 
stage static cell culture tests for biocompatibility of a material. In that case, the tensile 
properties of the textile are not relevant. Another value standing out is the large amount 
of 21 research articles utilizing non-wovens for cartilage tissue engineering applications. 
It is also worth noticing that embroideries have been used almost only in bone tissue 
engineering. The possibility to manufacture three dimensional scaffolds with controlled 
dimensions is desirable for filling bone defects.  
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Figure 21. The most common intended tissue engineering applications and 
types of textiles used for each. B=braided, E=embroidered, K=knitted, N=non-
woven and W=woven. [Appendix A] 
Biotextiles are promising materials for tissue engineering applications. The versatility of 
the manufacturing techniques allows processing structures with a wide range of properties 
to address mechanical requirements and to provide a hospitable environment for cells. 
The main challenge remains to combine modern manufacturing techniques, biomaterials 
and advances in biological research to process tissues or organs, preferably in a seamless 
automated process. Extensive research must be conducted to develop products that have 
mechanical and biological properties that are comparable to live organs and tissues. Be-
sides regenerative medicine, tissue engineered biotextiles could be utilized as in vitro 
disease models and drug testing. [3; 54] 
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3. PRELIMINARY EXPERIMENTS 
The aim of the preliminary experiments was to learn about the possibilities and limitations 
of the available equipment. For example, requirements for mechanical properties of the 
fibers and range of possible pore sizes in textiles were of interest. Fiber properties such 
as tensile strength and stiffness affect its ability to be processed into textile structures. 
Acquired information guided in choosing a suitable fiber and designing the manufactur-
ing and testing process for the scaffolds. Stages of the preliminary experiments are shown 
in Figure 22. 
 
Figure 22. Workflow of the preliminary experiments. 
Some of the stages are described in more detail, accompanied by illustrations in the ma-
terials and methods chapter. This way more emphasis is put on the chapter which covers 
manufacturing of the scaffolds for cell culturing. 
3.1 Textile manufacturing 
Four types of fibers were used in the preliminary experiments. The selection was based 
on ready availability at TUT where all of the fibers were previously produced. To evaluate 
requirements of fiber properties for textile manufacturing, it was advantageous to have 
fibers made of several different materials and in varying cross-sectional diameters to com-
pare. Information on the fibers can be found in Table 1. From the fibers shown, fibers F3 
and F4 have similar properties. The latter was introduced to the study because the fiber 
F3 inhibited curliness, which can lead to unwanted entanglement during processing.  
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Table 1. Properties of the fibers used in the preliminary experiments.  
Name Material 
Cross-sectional diameter 
(µm) 
Cross-sectional shape Filaments 
F1 PLA/PEG 95/5 106 round 4 
F2 PBS/PLA 75/25 104 round 4 
F3 PLDLA 96/4 56 star 4 
F4 PLDLA 96/4 65 star 4 
 
Knitted, woven, braided and embroidered textiles were manufactured using the fibers in 
Table 1. The processes and results are discussed in the next subsections. 
3.1.1 Knitting 
Single jersey knits were manufactured with circular knitting machine ELHA R-1S by 
Textilmaschinenfabrik Harry Lucas GmbH (Neumünster, Germany). A cylinder with di-
ameter of 0.5 inches was used. To observe variation in the loop size, the fabrics were 
knitted with both 9 (every other) and 19 (all) needles using two needle lifting heights. 
Other controllable variables included machine speed, yarn tension, fabric withdrawal ten-
sion and feed position of the yarn. These do not affect the loop size, but need to be ad-
justed to successfully operate the machine. 
Knitting settings and properties of the knits are combined to Table 2. The measurements 
to determine the loop size were taken from the middle of the 4-ply yarn bundle. Course 
and wale densities were calculated with measurements taken with a common office ruler 
with 1 mm accuracy. 
Table 2. Circular knitting machine settings and textile properties from the preliminary 
study. N = 3 for the loop lengths and pore sizes. 
Name Fiber Needles 
Needle lifting 
height (mm) 
Loop 
length 
(mm) 
Pore 
size 
(mm2) 
Courses 
/cm 
Wales 
/cm 
K1-F1-9N-H F1 9 HIGH 9 1.18 4 6 
K2-F2-9N-H F2 9 HIGH 8 0.87 5 6 
K3-F3-9N-H F3 9 HIGH 8 0.92 4 7 
K4-F1-9N-L F1 9 LOW 8 0.65 4 7 
K5-F2-9N-L F2 9 LOW 8 1.14 5 6 
K6-F3-9N-L F3 9 LOW 7 0.87 5 6 
K7-F2-19N-H F2 19 HIGH 8 0.87 4 6 
K8-F3-19N-H F3 19 HIGH 6 0.39 5 11 
K9-F3-19N-L F3 19 LOW 6 0.29 6 11 
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Knitting fiber F1 with 9 needles was problematic on both needle lifting heights. The nee-
dles were not able to catch the yarn, which resulted in holes in the knit. The yarn seemed 
not to be pliable enough and thus F1 was not chosen to be knitted with full set of 19 
needles. In comparison, fiber F2 was easier to knit with 9 needles. When switched to 19 
needles, the F2 was very problematic to knit having similar issues as F1 with 9 needles. 
F3 was successfully knitted with 19 needles on both needle lifting heights. The loop size 
with F3 was visibly smaller with 19 needles than with 9 needles. On 19 needles, lowering 
the needle lifting height did not have much effect on the loop size. Only the course density 
increased by one course per centimeter. These findings show that the densest single jersey 
knit with the smallest loop size can be manufactured from fibers with the smallest cross-
sectional diameter when using a full set of needles at low lifting height. However, the 
loops and pores were still quite large even at their smallest. The width of the loops was 
in the range of hundreds of micrometers. 
3.1.2 Weaving 
4-ply F2 and F4 yarns were used to manufacture approximately 10 mm wide strips of 
plain weave woven fabric using a tabletop hand loom by Brio AB (Malmö, Sweden). The 
fabrics will be referred to as W1-F2 and W2-F4. For this process, F3 was substituted with 
similar yarn F4 due to the curliness of F3. F1 was left out from the study after it was 
shown previously to be unsuitable for knitting.  
Warp and weft densities for the woven fabrics are presented in table 3. W2-F4 had small 
less dense areas where the weft density was as low as 40 yarns/cm. With an optical mi-
croscope no pores were clearly visible in any of the fabrics. Transparency of the fibers 
makes confirming the existence of small pores with diameters up to dozens of microme-
ters difficult from the images. Both yarns had sufficient mechanical properties for weav-
ing. Neither of the fibers here had a significant advantage over the other in the weaving 
process. 
Table 3. Properties of woven fabrics manufactured in the preliminary experiments. 
Name Yarn Warp density (yarns/cm) Weft density (yarns/cm) 
W1-F2 F2 20 33 
W2-F4 F4 20 125 
 
In addition, weaving by adding metal filaments to alternate with F2 or F4 was experi-
mented with. The aim was to create larger pores into the structure after removing the 
metal filaments. The weaving was not successful. The wefts were not oriented straight as 
the metal filaments did bend in an unwanted way when pressed with the beater. The struc-
ture did not resemble a traditional weave any more. Also especially in combination with 
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F4, the fibers did slide over the metal filaments. The metal filaments had cross-sectional 
diameters of 0.3 mm and 0.5 mm. 
3.1.3 Braiding 
A modified late 19th century braiding machine was used to manufacture eight braids from 
yarns F2 and F4. The machine can be used with 12 or 24 spools. For this preliminary 
experiment, 24 spools were used as it creates more dense braid. To reduce mechanical 
stress per filament, the filament count of F4 was increased to 8. Some of the samples were 
braided over a 2.75 mm plastic mandrel that was later removed. Two braiding positions, 
which affect the braid angle, were used. Lower position produces a braid with lower braid 
angle. The braid angle is the angle between the longitudinal axis of the braid and the yarn. 
For all samples regular 2:2-1 pattern was used. Braid properties are combined to Table 4. 
Table 4. Braiding machine settings and braid properties from the preliminary experi-
ments. N = 3 for braid angle. 
Name Fiber 
Filament 
count 
Braid 
angle  
ϴ (°) 
Braiding  
position 
Mandrel 
(Yes/No) 
Smallest pore 
(mm2) 
Largest pore 
(mm2) 
B1-F2-H F2 4 38 High No 0.004 0.024 
B2-F2-H-M F2 4 39 High Yes 0.217 0.489 
B3-F2-L-M F2 4 42 Low Yes 0.008 0.062 
B4-F2-L F2 4 42 Low No 0 0 
B5-F4-H F4 8 36 High No 0 0 
B6-F4-H-M F4 8 41 High Yes 0.106 0.363 
B7-F4-L-M F4 8 40 Low Yes 0 0 
B8-F4-L F4 8 42 Low No 0 0 
 
Braids using fiber F2 showed great amount of variation in pore size. The measured pores 
are located between the yarns. In some braids, there were also small pores between the 
fibers. Braiding with yarn F4 resulted in dense structures with no visible pores under 
microscope, except in braid B6 where the structure was loose in comparison. Using the 
mandrel increased the pore sizes in the structures with both yarns. If accompanied with 
high braiding position, the structures tended to be too loose to maintain their shape when 
handled after removing the mandrel. Both fibers had sufficient mechanical properties for 
braiding. 
To use the fibers with the braiding machine the fibers were first wound onto special 
wooden bobbins made for the braiding machine. A custom built winding line was assem-
bled for this purpose. The yarn winding process will be described in more detail in the 
materials and methods chapter of the experimental part. 
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3.1.4 Embroidery 
A sewing and embroidery machine Innov-is 955 by Brother Industries Ltd (Nagoya, Ja-
pan) was used to create stitched patterns on a plain weave cotton fabric. Embroidery pat-
terns were created in PE-Design Plus software and uploaded to the embroidery machine. 
The software has two wizards for creating patterns: Photo Stitch 1 (PS1) and Photo Stitch 
2 (PS2). For both wizards, a monochrome square was used as the initial image. Settings 
from the wizards and yarn specifications are combined to Table 5. In the PS1 and PS2 
settings, the far ends of line interval and density values were used. The run pitch value 
was the lowest possible. Higher density and line interval values result in more detailed 
stitching. Run pitch specifies the length of one stich. All samples were embroidered using 
a size 75/11 needle. 
Table 5. Embroidery settings from Brother® PE-Design Plus software and yarns used in 
the process. Top thread is on a spool and bottom thread on a bobbin. 
Photo Stitch 1       
Name Yarn (spool/bobbin) Coarse/Fine Run pitch (mm) 
E1-CC-C-PS1 Cotton/Cotton Coarse 2 
E2-CC-F-PS1 Cotton/Cotton Fine 2 
E7-F2C-C-PS1 F4/Cotton Coarse 2 
E8-F4C-F-PS1 F4/Cotton Fine 2 
E9-F2C-C-PS1 F2/Cotton Coarse 2 
E10-F2C-F-PS1 F2/Cotton Fine 2 
E11-F2F2-C-PS1 F2/F2 Coarse 2 
E12-F2F2-F-PS1 F2/F2 Fine 2 
Photo Stitch 2       
Name Yarn (spool/bobbin) density (lines/mm) Line inerval  
E3-CC-H-L-PS2 cotton/cotton 2.5 5 
E4-CC-H-H-PS2 cotton/cotton 5 5 
E5-CC-L-L-PS2 cotton/cotton 2.5 2.5 
E6-CC-L-H-PS2 cotton/cotton 5 2.5 
 
Samples E1-E6 were embroidered using common cotton embroidery yarns. To distin-
guish the top thread from the white base fabric, a black yarn was used. From these sam-
ples, it was easy to see how changing the settings in the wizards affected the end results. 
Embroids that were created using PS1 had the top thread covering the base fabric more 
evenly in comparison to ones created with PS2. In addition, the difference between coarse 
and fine density settings in PS1 was easy to see by naked eye. This lead only the PS1 to 
be used with following experiments with yarns F2 and F4 as it was more suitable for the 
intented purpose. 
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Fiber F4 did not have high enough mechanical properties. It was cut almost immediately 
after beginning the embroidery process and the samples E7 and E8 were not finished. F2 
endured moderately better. Manufacturing sample E9 with cotton bottom thread was com-
pleted without top thread being cut. E10 was completed as well but the top thread was cut 
once and entangled to the machines parts several times. In samples E11 and E12, fiber F2 
was used for both top and bottom threads, but entanglement continued to be a problem. 
Upon inspection with an optical microscope the samples embroidered with F2 and F4 had 
a lot of loose and randomly oriented filaments unlike in samples E1–6. The structure 
resembled more a non-woven fabric than a controlled stitching. The yarns F2 and F4 were 
not suitable for embroidery because of the entangling loose filaments and insufficient 
mechanical properties. The embroidery machine was not suitable for processing yarns 
with multiple loose filaments or low tensile strength. The method was therefore chosen 
not to be used for manufacturing scaffolds for the cell culture study. 
3.2 Microscopic imaging and image processing 
Image processing and analysis software ImageJ by National Institutes of Health (Rock-
ville, United States) was used to determine several structural attributes from digital im-
ages taken with a digital camera BUC4-500C by BestScope (Beijing, China) attached to 
an optical microscope 475110–9904 by Zeiss (Oberkochen ,Germany). Imaging soft-
ware ISCapture by Tucsen (Fuzhou, China) was used to take the images. From all tex-
tile types, pore size was measured. In addition, course and wale densities were measured 
from knits, warp and weft densities from woven fabrics and braid angle from braids. For 
each textile type, the measurements were taken from fabrics after manufacturing and 
from scaffolds after heat treatment. For both, one sample was examined from each tex-
tile type. 
3.3 Scaffold manufacturing 
To achieve more three-dimensional structures, knitted, braided and woven fabrics were 
processed into multi-layered scaffolds. For clarification, a tubular fabric was considered 
to have two layers. For each fabric, pieces of approximately 2 cm in length were arranged 
on top of each other and the ends melted together with an impulse sealer Magneta 621-
M52 by Audion (Weesp, The Netherlands). This was not possible for the braids that were 
manufactured without the mandrel as they weren’t wide and pliable enough to be arranged 
as described. In other knitted and braided fabrics, up to few millimeters wide gap was left 
within the tube. The woven scaffolds had smaller, but visible gaps as well between the 
layers. The gaps were removed by heat treating the scaffolds between steel plates under 
a weight. It was also of interest to approximate the number of layers necessary to manu-
facture a scaffold with a specific thickness as the scaffolds for cell cultruring were desired 
to have similar thicknesses. 
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To determine suitable temperature for heat treatment, scaffolds with 1 to 8 layers were 
kept at 60 ºC, 70 ºC, 80 ºC and 100 ºC for 15 minutes between steel plates. For compres-
sion, a 400 g steel plate was added. In addition, adding 0.5–1.0 mm thick steel frames 
around the samples was experimented with. These frames prevented excess compression 
of the samples allowing to include more layers while minimizing changes in structure. 
After heating, the fabrics were cooled between the plates under the weight at room tem-
perature for five minutes before visual inspection.  
70–80 ºC was found to be a suitable temperature range for the heat treatment as the layers 
stayed compressed together, but did not melt. Woven scaffolds did not require the use of 
frames, but for knits and braids with 4 or more layers it seemed to have some advantage. 
Also, it was evident that a less dense structure led to larger changes in the structures of 
knits and braids. This was not layer count dependant. 
3.4 Recovery after heat treatment and compression 
The cell culturing would take place at least several weeks after manufacturing the scaf-
folds, therefore it was necessary to investigate how the scaffolds behaved after the heat 
treatment. The scaffolds should stay in their compressed state to avoid large gaps between 
the layers. One knitted fabric, two woven fabrics and four braids were chosen for this 
experiment. Scaffolds prepared from these fabrics preserved their original characteristic 
structure trough the heat treatment process on at least satisfactory level. 
The scaffolds were kept at 80 ºC for 15 minutes between steel plates under a 400 g weight 
and allowed to cool at room temperature for 5 minutes before they were removed from 
between the plates. Five scaffolds were prepared from each fabric. The length, width and 
thickness of the scaffolds was measured with a digital caliper before the heat treatment 
and at 0 h, 1 h, 20 h and 7 d after the treatment. Visual inspection of the structure was 
done immediately after the heat treatment. Comments can be found in Table 6.  From the 
scaffolds, braid B6 experienced greatest structural changes. The yarns had moved in re-
lation to each other and the structure did not look like a typical braid. Other braids had 
some loose loops at the edges, but the center areas were mostly as before heat treatment. 
The knit and the woven fabrics held their initial structure very well. 
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Table 6. Fabrics used in the recovery experiment, layer count for each fabric and com-
ments on appearance after heat treatment. 
Sample Layers Comments 
B2-F2-H-M 6 
Appearance mostly good, but also includes areas where the braid has 
lost its characteristic structure. 
B3-F2-L-M 4 
Attached from the ends to the surface with a tape to keep upright. After 
compression layers were misaligned. 
B6-F4-H-M  8 Charasteristic structure lost in processing. 
B7-F4-L-M  4 Appearance good at the center, poor at the edges. 
K9-F3-19N-L 8 Appearance very good. 
W1-F2 3 Layers tightly packed, but not fused. Appearance very good. 
W2-F4 4 Layers tightly packed, but not fused. Appearance very good. 
 
From Figure 23 can be seen that none of the scaffolds exhibited significant changes in 
their dimensions after the heat treatment. For each sample, measurements taken at 0 h, 
1 h, 20 h and 7 d were compared to the dimensions prior to the heat treatment. The graph 
presents average percentages for each sample type. 
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Figure 23. Relative changes in length, width and thickness after heat treatment 
of braided, knitted and woven scaffolds. (n=5). 
Both visual inspection and measurements indicated that it was possible to use heat treat-
ment under compression method on all three textile types. The braids were the most sus-
ceptible to exhibit unwanted structural changes. However, good results with sample B6 
showed that the typical structure of the braid could be preserved. 
3.5 Swelling in liquid 
As the scaffolds would be kept in a cell culture medium during the cell culture studies, it 
was necessary to study if the liquid environment caused unwanted behavior, such as ex-
cess swelling or floating. Swelling could affect the flatness of the structure and cause the 
scaffolds to fall on their side, which would disturb micrography. 
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Braided, knitted and woven samples were kept in a sodium phosphate-buffered saline 
solution (NaPBS) in an incubator at 37 °C for a week. Length, width and thickness were 
measured with a caliper at 0 h, 1 h, 2 h, 4 h, 21 h and 7 d. Five samples were tested of 
each scaffold type. For each sample, all measurements were compared to the dimensions 
prior to adding the solution. Figure 24 presents average percentages for each sample type. 
 
Figure 24. Relative changes of braided, knitted and woven scaffolds during 
swelling experiment. n = 5. 
All of the scaffolds floated on the surface when the liquid was added because air was 
trapped inside the scaffolds. To remove the air, the scaffolds were tapped with blunt ended 
forceps while submerged. This was repeated at each time point until the scaffolds stayed 
under surface. Only a few scaffolds needed this at 21 h. All of the scaffolds were sub-
merged at 7 d. In addition, an observation was made where air was trapped into the 
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seamed end of a sample. Because of this, the sample was not flat on the bottom of the 
bottle. One end was touching the bottom and other was floating a few millimeters above 
the bottom. 
The changes in length, width and thickness were very small. A difference could be also 
due to measuring from a slightly different part of the scaffold. As a conclusion, the 
changes were not significant as they were not visible to naked eye. 
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4. MATERIALS AND METHODS 
The main experimental part of the thesis begun with melt spinning PLDLA 96/4 fibers. 
A 36-week hydrolytic degradation study was conducted simultaneously with other stages 
shown in Figure 25. Three types of textile scaffolds were manufactured to be used in the 
cell culture study. 
 
Figure 25. Workflow of the main experimental part of the thesis.  
Materials and methods used in the different manufacturing and testing stages and in the 
cell culture study will be presented in the following sections. The design of the main 
experimental part of the thesis is based on the preliminary experiments. Only hydrolytic 
degradation study, gamma irradiation process and cell culture study were not included in 
the preliminary part. 
4.1 Fiber processing 
Melt spinning method was used to manufacture polymer fibers. The information of the 
used material and basis for materials selection is presented in the next section, which is 
followed by a description of the fiber manufacturing process. Details of the production 
line and processing parameters are given. 
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4.1.1 Material 
Good manufacturing practice (GMP) grade PLDLA copolymer Purasorb® PLD 9620 
with 96/4 molar ratio of L- and D-lactides by Corbion Purac Biomaterials (Gorinchem, 
The Netherlands) was used in this study to manufacture continuous fibers with a melt 
spinning method. Material data is combined to Table 7. 
Table 7. PLDLA 96/4 material information [55]. 
Tradename Purasorb® PLD 9620 
L/D molar ratio (%) 96/4 
Inherent viscosity (dL/g) 1.92 
Form Granule 
Batch 1405002058 
Manufacturer Corbion Purac Biomaterials 
 
Preliminary experiments showed PLDLA 96/4 to be suitable for manufacturing textiles 
and it was of interest to compare results from these experiments to results from previous 
unpublished experiments with the same polymer. Fibers F3 and F4 that were used in the 
preliminary experiments were manufactured from a different batch of the same polymer. 
4.1.2 Melt spinning 
The melt spinning line (Figure 26) consisted of a K-SFS-24 gravimetric feeder by Co-
perion K-Tron (Stuttgart, Germany), a Gimac TR 12/24 GM single screw micro extruder 
by Gimac di Maccagnan Giorgio (Milano, Italy), five draw panels by Fourné Maschinen-
bau GmbH (Alfter, Germany) and a RPC.HS filament winder by Comoli (Paruzzaro, It-
aly). Technical details of the extruder can be found in Table 8. 
 
Figure 26. Illustration of the melt spinning line used to manufacture PLDLA 
96/4 fibers from granules to form a 4-ply multifilament yarn. 
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Table 8. Technical details of Gimac TR 12/24 GM single screw micro extruder. 
Extruder Gimac TR 12/24 GM 
Screw diameter (mm) 12 
Screw Length/Diameter ratio 24/1 
Number of heating zones 6 
Melt temperature sensor Heating Zone 5 
Pressure sensor Heating Zone 5 
Die 4 x Ø 0.4 mm (round) 
 
In the process, polymer granules were inserted to the feeder, which dispensed the granules 
to the extruder at a constant rate of 150 g/h. Nitrogen gas was pumped into the hoppers 
of both the feeder and the extruder to replace atmospheric oxygen. The polymer was 
melted in the extruder at elevated temperature and was forced through a die with four 
round holes 0.4 mm in diameter each. The extruder was cooled with a FL1203 recirculat-
ing water cooler by Julabo GmbH (Seelbach, Germany), which was set to operate at 
10 °C. After extrusion, the fiber was cooled by airflow. The godets on draw panels 
MONO2, DUO1 and DUO2 were heated to temperatures presented in Table 9. Table 10 
presents information on drawing velocities and number of rounds the fiber makes around 
a godet or a pair of godets. Cross-sectional diameters of the fibers were measured with a 
digital micrometer. Air humidity was at 20 % during processing. 
Table 9. Temperature settings for PLDLA 96/4 extrusion. 
Heating zone Temperature setting (°C) 
1 182 
2 187 
3 192 
4 203 
5 214 
6 237 
 
Table 10. Fiber drawing parameters for melt spinning process of PLDLA 96/4. 
Draw panel Godet temperature (°C) Drawing velocity (m/min) Number of rounds 
MONO1 - 70 1 
MONO2 70 72 5 
DUO1 85 130 6 
DUO2 90 220 10 
MONO3 - 222 1 
Winder - 225 - 
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Prior to melt spinning the polymer granules were dried in a VD-series vacuum drying 
oven by WTC Binder GmbH (Tuttlingen, Germany). The uncapped bottles with the pol-
ymer were kept in the vacuum over night at room temperature, which was followed by 
16h at 100 °C. After heating, the granules were allowed to cool to room temperature in 
the vacuum and kept there until extrusion.  
4.2 Textile manufacturing 
Three types of textiles were manufactured from the PLDLA 96/4 fibers. The manufactur-
ing methods were braiding, knitting and weaving. For each method fibers were used as 
non-twisted bundles, yarns. 8-ply yarn was used for braiding to reduce mechanical stress 
experienced by a single fiber. For other methods 4-ply yarn was used. Each manufactur-
ing method is described in following subsections. 
Microscopic imaging and image processing methods were used to determine properties 
of textiles before processing using devices and methods previously described in section 
3.2. Briefly, from all textile types, pore size was measured. In addition, course/wale den-
sities were measured from knits and warp/weft densities from woven fabrics. Braid angle 
was determined from braids. 
4.2.1 Braiding 
A modified late 19th century braiding machine was used to manufacture a tubular braid. 
For braiding, 4-ply PLDLA 96/4 yarn was wound from two spools to a single bobbin to 
double the filament count to 8 using a custom yarn winding line (Figure 27). In the pro-
cess, the winder pulled the yarn from two spools onto a bobbin. A series of yarn guides 
were used to allow the winder to pull the yarn from the spools as smoothly as possible. 
In the winder, a carriage section distributed the yarn evenly on the bobbin with a steady 
back and forth motion. The winder was set to wind the yarn at a velocity of approximately 
0.4 m/s. 
 
Figure 27. A simplified illustration of the yarn winding line. 
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Figure 28. Yarn winding machine. The path of the yarn is highlighted in red. 
A=velocity control lever, B=carriage and C=bobbin. 
A 2:2-1 braid was manufactured using a full set of 24 bobbins. The yarns were braided 
over a flexible hollow plastic mandrel with a diameter of 2.75 mm, which was later re-
moved. The braiding position (see Figure 29) was kept at the level of the lower yarn guide 
by adjusting the tension of the winder manually. Lower position results in higher braiding 
angle. To accompany the simplified illustration a photograph of the machine is included 
(Figure 30).  
 
Figure 29. A simplified illustration of the braiding machine. 
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Figure 30. Braiding machine. Lower yarn guide in pink.  
After braiding, the braid was washed in Etax Aa 99.5 % ethanol by Altia Oyj (Helsinki, 
Finland) in an M12 ultrasonic cleaner by FinnSonic (Lahti, Finland) 2 times to remove 
machine lubricants and other unwanted substances. Each washing cycle lasted for 2 
minutes and the ethanol was changed between cycles. The braid was dried in a fume hood 
overnight and stored in a vacuum drying oven at room temperature until used to prepare 
the scaffolds. 
4.2.2 Knitting 
A tubular single jersey knit was knitted from 4-ply PLDLA 96/4 yarn using an ELHA R-
1S circular knitting machine by Textilmaschinenfabrik Harry Lucas GmbH shown in Fig-
ure 31. A full set of 19 latch needles was used in the ½ inch cylinder. In addition to needle 
count and cylinder size, adjustable parameters were fabric withdrawal tension, needle 
lifting height, yarn tension and knitting speed. The two latter parameters did not have 
numerical values and the first-mentioned is a unitless parameter. Information on the ma-
chine and the used parameters are collected to Table 11. 
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Figure 31. ELHA R-1S circular knitting machine. 
Table 11. Machine and processing parameters for knitting. 
Parameter Value 
Cylinder ½" 
Needle count 19 of 19 
Needle lifting height 24.4–24.6 mm 
Yarn tension Low 
Knitting speed Low 
Fabric withdrawal tension 4.0–4.1 
 
To form a knit, the yarn is drawn from the spool by the motion of the needles. It is guided 
through yarn guides and a brake that is used to adjust the yarn tension. This is followed 
by a feed area where the yarn is set to be grabbed by the hook of a needle to form a loop 
to the knit. The circular knit is then drawn away from the needles with a fabric withdrawal 
mechanism, a nip roller. By controlling the rolling speed of the roller, the tension of the 
fabric between the needles and the roller is adjusted. Tension is needed to pull the fabric 
away from the needles to allow a new row of loops to form. See Figure 32 for an illustra-
tion of the knitting process. 
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Figure 32. A simplified illustration of the circular knit manufacturing process. 
The knit was washed in ethanol while treated with ultrasound as previously described in 
subsection 4.2.1. Lubricant used in the needle mechanism is in contact with the knit and 
therefore needs to be removed by washing. 
4.2.3 Weaving 
Plain weave fabric was manufactured by using a modified tabletop handloom by Brio AB 
shown in Figure 33. The original reeds of the beater were replaced with reeds that had 
higher slit density. By doing this, a higher warp yarn density was achieved. For both the 
warp and the weft, 4-ply PLDLA 96/4 yarn was used. To produce a fabric with a width 
of approximately 1 cm, 20 yarns were used in the warp. 
44 
 
Figure 33. Modified tabletop handloom and a shuttle for inserting the weft 
yarns. A=beater with modified reeds and B=shuttle. 
For weaving, approximately 100–150 cm of yarn was collected around the shuttle. A knot 
was made to both ends of the yarn to prevent it from unraveling. With the shuttle, the weft 
yarn was guided through the warp and secured to its place with the beater. After changing 
the position of the heddles, the shuttle was taken back to the other side through the warp. 
The yarn was again secured to its place with the beater. This was repeated until enough 
fabric was created.  
The fabric was washed in ethanol while treated with ultrasound as previously described 
in subsection 4.2.1. Unlike in braiding and knitting processes, lubricants were not used 
on the loom. However, the fabric was washed to remove for example dust gathered from 
the air. 
4.3 Scaffold manufacturing 
To perform recovery, swelling and cell culture studies, multilayered scaffolds were man-
ufactured from the previously braided, knitted and woven fabrics. The number of layers 
for each textile type was chosen so that all the final scaffolds would be approximately 
1 mm in thickness. To be able to fit the scaffolds into cell culture wells, the scaffolds were 
not to exceed 15 mm in any direction. For each scaffold, the layers were first heat sealed 
together from the ends prior to heat treatment under compression.  
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4.3.1 Layer arrangement and heat sealing 
Magneta 621-M52 impulse sealer by Audion was used to melt the PLDLA 96/4 fabrics 
to prevent unraveling of the fabrics and to join the layers. As mentioned earlier, tubular 
fabrics are considered to have two layers in one cross-section. To achieve approximately 
1 mm thick scaffolds, each fabric type was arranged to have different amount of layers 
(Table 12). The process (Figure 34) consisted of three main stages: (1) The fabric was 
divided into sections and cut, (2) the sections were arranged on top of each other and (3) 
the multilayered structure was heat sealed from the ends. At the third stage, the structure 
was held between forceps for sealing. The Figure 34 shows the process for knitted scaf-
folds. Braided and woven fabrics were treated in similar manner except the layer count 
and therefore the amount of sections differed. In some cases, not all of the sections were 
joined from the ends before seaming at stage 3. Especially with braided scaffolds it was 
sometimes necessary to separate the sections to arrange them accurately on top of each 
other for stage 3. This was because of high thickness to width ratio. 
Table 12. PLDLA 96/4 textile scaffolds were prepared by heat treatment.  
Textile type Scaffolds manufactured Notation Layer count 
Braided 20 B1–B20 6 
Knitted 24 K1–K24 8 
Woven 21 W1–W21 3 
 
 
Figure 34. Preparing the PLDLA 96/4 textile fabrics into multilayered struc-
tures consisted of three main stages. 
The same heating and cooling parameter values (Table 13) were used for all textile types. 
With these settings it was necessary to use the sealer on the both sides of the structure at 
stage 3 of the process to melt the ends firmly together. 
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Table 13. Impulse sealer settings used in preparing PLDLA 96/4 textile scaffolds. 
Parameter Value 
Heating 6–7 
Cooling 6 
 
Heat treatment under compression for the structures was done immediately after seaming. 
The process is presented in the following subsection. 
4.3.2 Heat treatment under compression 
The textile scaffolds were heat treated in a laboratory drying oven at 70 °C for 15 minutes 
and allowed to cool at room temperature for 5 minutes before removing the samples from 
the setup. For the treatment, the scaffolds were placed on a steel plate and a 0.5 mm thick 
steel frame was added around the scaffolds. Compression was created by adding a 592 g 
steel plate on the top of the assembly as shown in Figure 35.  
 
Figure 35. PLDLA 96/4 scaffolds were heat treated under compression. A 
0.5 mm frame surrounded the samples to prevent excess compression. 
A polytetrafluoroethylene (PTFE) adhesive tape was used on one end of braided scaffolds 
to maintain correct position. Because of the high thickness to width ratio of the braids, 
they were subjective to fall on their side. Minimum contact was made with the tape to the 
scaffolds. Covering only the melted seam at the end of the scaffold was enough. 
4.4 Gamma irradiation 
The scaffolds for cell culture, recovery and swelling tests and fibers for in vitro hydrolytic 
degradation study were sterilized with gamma-irradiation. A dose of  ≥25 kGy was given 
at BBF Sterilisationsservice GmbH (Kernen, Germany). Gamma irradiation indicator la-
bels were used to confirm received dose. For sterilization, the samples were packed into 
plastic pouches, which were inserted to metallic zip lock bags. The latter were packed 
into a cardboard box to be sent out for irradiation. All other scaffolds were heat treated 
prior to irradiation except B17–B20, K16–K19 and W16–W19 which were to be used on 
47 
recovery and swelling studies. Before the scaffolds were packaged to be gamma irradi-
ated, they were washed in 99.5 % ethanol as previously as described previously in sub-
section 4.2.1. 
4.5 Recovery of the scaffolds after heat treatment 
To study if the scaffolds maintained their compressed state after the heat treatment textile 
scaffolds were heat treated under compression and the dimensions were measured during 
a 1-week period. Four gamma irradiated scaffolds were tested from each textile type. Heat 
treatment procedure was the same as described earlier in subsection 4.3.2. After the treat-
ment, the samples were stored in closed plastic bottles at room temperature to be used in 
swelling experiment. Length, width and thickness were measured with a digital caliper 
before the heat treatment, immediately after and at 4 h, 1 d and 7 d time points. Measure-
ments from the latter four were compared to ones taken before the treatment and percen-
tual changes were calculated. 
4.6 Swelling of the scaffolds in cell culture medium 
A swelling study was conducted for textile scaffolds. The same scaffolds were previously 
used in the recovery study. Scaffolds were kept submerged in Dulbecco's Modified Eagle 
Medium: Nutrient Mixture F-12 (DMEM/F-12) by Thermo Fisher Scientific (Waltham, 
United States) in an incubator (unknown model) by Termaks AS (Bergen, Norway) at 
37 °C for 1 week period. Each scaffold was stored in an individual closed plastic bottle. 
Length, width and thickness of all scaffolds was measured with a digital caliper before 
the scaffolds were inserted to the medium. The samples were inspected for contamination 
every 24 h and contaminated samples were removed and measured. At 7 days also non-
contaminated samples were measured and discarded. Change of color from pink to yellow 
in the culture medium indicated contamination. 
When the scaffolds were inserted into the medium, there was air trapped inside the scaf-
folds. This air was removed by tapping the bottoms of the bottles against the work surface 
of a KR-140 laminar flow cabinet by Kojair Tech Oy (Tampere, Finland). 
To avoid contamination, the scaffolds were first washed in 99.5 % ethanol as previously 
as described previously in subsection 4.2.1. Inserting the scaffolds into the cell culture 
medium and later measurements were done as aseptically as possible in a laminar flow 
cabinet. The laminar cabinet was located in a laboratory, which was not designed for 
aseptic working. 
4.7 Hydrolytic degradation of the fibers 
A hydrolysis study was conducted for the gamma irradiated PLDLA 96/4 fibers to deter-
mine in vitro degradation properties of the fibers. Time points for the 36-week series are 
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shown in Table 14. Tensile testing and differential scanning calorimetry methods were 
used to determine mechanical properties, thermal properties and crystallinity of the poly-
mer fibers. 
Table 14. Time points for in vitro hydrolytic degradation study of the PLDLA 96/4 
fibers. Y=YES. 
Method Timepoints (week) 
  0 DRY 0 WET 1 2 3 4 8 12 16 20 24 28 32 36 
Tensile Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
DSC Y - Y - - - Y - Y - Y Y - Y 
 
For tensile testing, 4-ply fiber bundles were cut into 25 cm sections and tied from one 
end. 8 bundles were prepared for each time point. DSC samples were prepared from 2.5 m 
sections of the 4-ply bundle, one section for each time point. The samples were sterilized 
with gamma irradiation as described earlier. 
The fibers for weeks 1–36 were placed in closed 35 ml test tubes filled with sodium phos-
phate-buffered saline solution (NaPBS) and kept in a static incubator at 37 °C. A test tube 
containing only NaPBS was included as a control. Composition of the solution is pre-
sented in Table 15.  
Table 15. Sodium phosphate-buffered saline solution composition. 
Reagent Amount (g/l) Concentration (mol/l) 
Na₂HPO₄ 3.54 0.0249 
NaH₂PO₄*H₂O  0.76 0.0055 
NaCl 5.90 0.1009 
 
The solutions pH was 7.35–7.45. The solution was changed every two weeks. For moni-
toring, pH was measured from the control and 5 other test tubes before changing the so-
lution. For pH measurements, a SevenMulti pH-meter by Mettler-Toledo (Columbus, 
United States) was used. When the fibers were first inserted to the solution and every time 
the solution was changed, the test tubes were turned upside down a couple of times the 
next day to remove air bubbles from the surfaces of the fibers. Samples for week 0 were 
stored in sealed plastic pouches at room temperature until used. 
4.7.1 Mechanical properties 
An Instron 4411 material testing machine by Instron (Norwood, United States) was used 
to conduct tensile testing for the PLDLA 96/4 fibers. Testing parameters are listed in 
Table 16. For each week, 6 parallel samples were tested, leaving 2 spare samples for every 
time point. 
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Table 16. The parameters used in tensile testing of the PLDLA 96/4 fibers. 
Parameter Value 
Load cell 500 N 
Gauge length 50 mm 
Crosshead speed 30 mm/min 
Temperature room 
 
The tensile strength of the 4-ply yarn was calculated using equation (1): 
𝜎 =
𝐹
𝐴
  ,     (1) 
where σ denotes tensile strength or stress (N/mm2 = MPa), F is tensile load (N) and A is 
cross sectional area (mm2) of the specimen. The cross-sectional diameters of the fibers 
were measured with a digital micrometer at 0, 1, 2 and 3 week time points. The diameters 
were used to calculate cross-sectional areas for the fibers. To calculate the total cross-
sectional area of the 4-ply yarn, the areas of the individual fibers were summed together. 
Measurements from the first 3 weeks were used to calculate an average cross-sectional 
area to be used from week 4 onward in the calculations. 
Before tensile testing, the samples were taken from the static incubator to room tempera-
ture a few hours before the measurements. Immediately before testing, each sample was 
taken from the buffer solution, rinsed with distilled water and measured with a microme-
ter when necessary. At week 0, the wet samples were placed in buffer solution 1 h before 
testing and also rinsed immediately before the testing. The dry samples were tested as 
they were removed from the sealed plastic pouches used for gamma irradiation. 
4.7.2 Thermal properties 
A Q1000 differential scanning calorimeter by TAinstruments (New Castle, United States) 
was used to determine the crystallinity (Xc), melting temperature (Tm) and glass transition 
temperature (Tg) of sterilized PLDLA 96/4 fibers at time points shown in Table 14 in 
section 4.7. The fiber was rolled into 5 mg (± 3 mg) balls to fit into standard aluminum 
sample pans. Encapsulating press was used to close the pans. The test method included 
two heating cycles from 0 to 200 °C at the rate of 20 °C/min. Xc was calculated using 
equation (2): 
∆𝐻𝑚𝑒𝑙𝑡𝑖𝑛𝑔
93.7 𝐽/𝑔
 × 100 %  ,    (2) 
where ∆Hmelting is melting enthalpy obtained from the melting peak in the DSC thermo-
gram and 93.7 J/g is melting enthalpy value for 100 % crystalline PLLA. Two parallel 
samples were used. 
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DSC samples were removed from the test tubes at set time points and washed with dis-
tilled water. After washing the samples were dried in a fume hood overnight and stored 
in vacuum for several days before packing into sealed plastic pouches. Samples from the 
first six time points were analyzed together and the samples from the last time point sep-
arately. 
4.8 In vitro cell culture study 
The in vitro cell culture study was conducted in the Adult Stem Cell Research group 
laboratories at the Institute of Biosciences and Medical Technology (BioMediTech), Uni-
versity of Tampere. Two types of cryopreserved human cells were used in the study, hu-
man urothelial cells (hUC) and human foreskin fibroblasts (hFF). The isolation of hUCs 
from patients was performed as previously described by Sartoneva et al. in 2011 [56]. 
hUCs from passage 5 were used in this study. The hFFs, passage 14, were from CCD-
1112Sk CRL-2429 cell line by ATTC (Manassas, United States). 
Cryopreserved cells were taken from nitrogen gas phase storage and thawed in a 37 °C 
water bath. Dimethyl sulfoxide as used as a cryoprotectant in the freezing solution. Im-
mediately after thawing the cells were suspended into cell culture medium, centrifuged 
5 min at 1000 rpm, again suspended into cell culture medium and transferred into T75 cell 
culture flasks by Nunc (Roskilde, Denmark). The cells were incubated in humidified at-
mosphere at 37 °C with 5 % CO2 in Forma Steri-Cycle i160 CO2 incubator by Thermo 
Fisher Scientific for 48 h. The hUCs were passaged by washing the cells in each bottle 
with 5 ml of Gibco Hank's Balanced Salt Solution (HBSS) by Thermo Fisher Scientific 
and detaching the cells with 3 ml of Gibco TrypLE Select enzymes by Thermo Fisher 
Scientific. The hFFs were passaged similarly, except Dulbecco’s Phosphate Buffered Sa-
line by Lonza (Verviers, Belgium) was used for washing instead of HBSS. The cells were 
incubated with the enzymes for 5–10 min. 5 ml of sterile filtrated 10 %  Human Serum in 
HBSS was used to inactivate the enzymes in each flask. The suspensions were collected 
into two bottles, one for each cell type and centrifuged at 1000 rpm for 5 min. The formed 
cell pellets were suspended in cell culture mediums. Epilife Calcium-free cell culture me-
dium base by Life Technologies (Carlsbad, United States) supplemented with penicillin 
and streptomycin antibiotics by Lonza, 1 % EpiLife Defined Growth Supplement by Life 
Technologies and 0.1 % 0.06 M CaCl2 by Life Technologies was used for hUCs. 
DMEM/F-12 medium base by Thermo Fisher Scientific supplemented with 5 % human 
serum, 1 % penicillin and streptomycin antibiotics and 1 % GlutaMAX L-glutamine by 
Thermo Fisher Scientific for the hFFs. A Bürker chamber was used to count the cells. 
Pre-wetted scaffolds were inserted into Nunclon delta 24 well multidishes by Nunc. 2 
parallel samples were used from each fabric type for both cell types. 50 µl of cell suspen-
sion was pipetted on the top of each scaffold 2 hours before adding 1 ml of cell culture 
medium to each well, supplemented Epilife for hUCs and supplemented DMEM/F-12 for 
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hFFs. This seeding procedure allowed the cells to attach better to the scaffolds before the 
mediums were added. 50 µl of cell suspension corresponds to 40 703 hUCs cells and 
50 000 hFFs. The cells were incubated at 37 °C with 5 % CO2. The mediums were 
changed every 3–4 days. Cell viability and distribution was qualitatively analyzed and 
micrographs were taken after 1, 4, 7 and 14 days of cell culture. 
4.8.1 Pre-wetting of the scaffolds 
The textile scaffolds were pre-wetted in cell culture medium 48 h before seeding to in-
crease hydrophilicity of the biomaterial. Scaffolds were assorted to 50 ml falcon tubes by 
type of scaffold. 10 ml of medium was added to each tube. Trapped air was removed from 
the scaffolds by tapping the tubes against a table until the scaffolds remained submerged. 
The tubes were stored in an incubator at 37 °C until the cell seeding. 
4.8.2 Cell viability and distribution 
Cell viability and distribution on the surfaces of the scaffolds was qualitatively assessed 
after 1, 4, 7 and 14 days of cell culture. On days 1, 7 and 14 Live/Dead staining was used 
and on day 4 crystal violet staining. Micrographs were taken for evaluation. Total of 24 
samples were used, 2 parallel samples from each fabric type for both cell types. 
For Live/Dead staining a LIVE/DEAD Viability/Cytotoxicity Kit for mammalian cells 
by Invitrogen Molecular Probes (Eugene, United States) was used. Two probes are used 
in this method, calcein acetoxymethyl ester (CAM) to produce green fluorescence and 
ethidium homodimer-1 (EthD-1) for red fluorescence. Cell culture medium was removed 
from the wells and 1 ml of DPBS (Dulbecco's Phosphate-Buffered Saline) was added to 
wash the scaffolds. A working solution containing 0.036 µM EthD-1 and 0.5 µM CAM 
in DPBS was prepared and used to replace the DPBS in the wells. The seeded scaffolds 
in the working solution were dark incubated at room temperature on a slow tilt shaker for 
30 min. Working solution was removed and replaced with DPBS. Scaffolds were trans-
ferred to clean wells containing 1 ml DPBS each for viewing and imaging. Images were 
taken with an IX51 fluorescence microscope by Olympus (Tokyo, Japan) and DP30BW 
camera by Olympus. Live cells were shown in green and dead cells in red. 
For crystal violet staining, the cell culture medium was removed from the wells and re-
placed with DPBS to wash the scaffolds. A fixing solution was prepared by diluting glu-
taraldehyde to 5 % using DPBS. The fixing solution was pipetted into the wells after 
removing DPBS and incubated for 30 min to fix the live cells. After the fixing solution 
was removed, the scaffolds were washed twice with type II water. 0.1 % crystal violet 
dye was filtrated through paper and added to the wells after washing to be incubated for 
20 min. The scaffolds were gently washed with type II water until no dye was visible in 
the water and allowed to dry. For micrography, the scaffolds were transferred to clean 
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wells. Two microscopes and cameras were used to take images: (i) Axio Vert.A1 micro-
scope, AxioCam MRc5 camera and Zen Blue Edition software, all by Zeiss and (ii) 
475110 – 9904 microscope by Zeiss, BUC4-500C camera by BestScope and ISCapture 
software by Tucsen. 
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5. RESULTS AND DISCUSSION 
The results and discussion chapter is divided into three sections. The first section presents 
the fiber and scaffold properties along with the results from the recovery after heat treat-
ment and the swelling in cell culture medium studies. The second section covers the hy-
drolytic degradation studies including tensile testing and DSC analysis. In the last section, 
the results from the in vitro cell culture study with hUCs and hFFs are presented. 
5.1 Textile scaffolds 
Experiments were performed to study the scaffolds behavior during heat processing and 
cell culture study. General properties of the fibers, textiles and scaffolds are presented in 
the following subsections. 
5.1.1 Fiber and textile properties 
The melt spun 4-filament PLDLA 96/4 fibers used in the scaffolds had an average diam-
eter of 44 µm, when individual measurements ranged from 33 µm to 52 µm (n = 40). The 
cross-sectional shape of the fibers was round. General properties of the textiles used in 
the scaffolds can be found in Table 17. The textiles used in scaffold manufacturing are 
shown in Figure 36. 
Table 17. Properties of textiles used for PLDLA 96/4 scaffolds. 
Textile type 
Filament 
count 
Min. pore 
size (mm2) 
Max. Pore 
size (mm2)  
Ave. pore 
size (mm2) 
Braid angle (°) 
Braided 8 0.001 0.027 0.014 37 
Knitted 4 0.164 0.539 0.352 N/A 
Woven 4 0 0 0 N/A 
Textile type 
Loop 
length 
(mm) 
Courses/cm Wales/cm 
Warp density 
(yarns/cm) 
Weft density 
(yarns/cm) 
Braided N/A N/A N/A N/A N/A 
Knitted 6 5 12 N/A N/A 
Woven N/A N/A N/A 22 116 
 
A great difference was seen between the pore sizes of the textiles. The woven fabrics 
were so dense that no pores was clearly visible when observing with a microscope. Trans-
parency of the fibers and shadows made it impossible to confirm if there where were very 
small pores present. Pores in the knitted fabric were easily visible to the naked eye, as 
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were the largest pores in the braided structures. As can be seen in Figure 36, the loops in 
the knits were vastly larger than in other textile types. 
 
Figure 36. From left to right: braided, knitted and woven PLDLA 96/4 textiles before 
processing. Knitted and woven structures are not shown in their complete width. Scale 
bar 1 mm. 
From these three manufacturing methods and associated devices, braiding provided the 
most control over the pore size, while weaving provided practically no control. The knits 
were manufactured with the smallest loop size possible, but the difference in pore sizes 
between the textile types remained large. The pore size in the braids was chosen to be 
between the pore sizes of the knits and the woven fabrics. It would have been desirable 
to manufacture structures with more uniform pore sizes for this study. The combination 
of this yarn and the used manufacturing devices limited the possibilities in this regard. 
5.1.2 Recovery after heat treatment and compression 
The recovery study showed that all scaffold types remained very well in their compressed 
state after the heat treatment and compression as can be seen in Figure 37. After the heat 
treatment and compression, the greatest change was observed in thickness of the scaf-
folds. The changes in length and width remained within a few percent range. 
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Figure 37. Recovery of PLDLA 96/4 scaffolds after heat treatment. N = 4. 
The results suggested that the dimensions of the scaffolds would not change significantly 
between the heat treatment process and the cell culture study. For the separately manu-
factured cell culture scaffolds the time between the heat treatment and cell seeding was 6 
weeks. During this period, the scaffolds were gamma irradiated. 
5.1.3 Swelling in cell culture medium 
Figure 38 shows the woven scaffolds to experience the least changes in dimensions. The 
values stayed very close to the initial measurements throughout the 1-week experiment. 
In braided and knitted scaffolds, the changes were larger, especially in thickness. The less 
dense structure of the braided and knitted scaffolds allows the cell culture medium to 
penetrate more easily and in larger volumes. Still, the change was barely visible to the 
naked eye and was not significant for cell culture purpose. 
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Figure 38. Swelling of PLDLA 96/4 scaffolds in DMEM/F-12 cell culture me-
dium after heat treatment. N = 4.  
As stated in the materials and methods section, contaminated scaffolds were removed on 
the day of observation and measured. For this reason, some time points contain measure-
ments from only one sample and therefore do not have standard deviation error bars pre-
sent in Figure 38. After 2 days one knitted scaffold was removed, after 3 days one woven 
scaffold, after 4 days one braided, two knitted and one woven scaffold and after 5 days 
one woven scaffold. Having more parallel samples would have provided more accurate 
prediction on future behavior, but this study provided enough confidence that swelling 
would not be an issue during the cell culture study. 
5.2 Hydrolytic degradation study of the fibers 
A 36-week hydrolytic degradation study was performed for the PLDLA 96/4 fibers. 
Changes in mechanical properties were studied using a tensile testing method. DSC anal-
ysis was performed to measure changes in crystallinity and in thermal properties such as 
glass transition and melting temperatures. The results are presented and discussed in the 
following subsections. Determining molecular weight of the samples at each time point 
would have been desirable, but was not possible due to a malfunctioning gel permeation 
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chromatography (GPC) device. The molecular weights of polymer chains affect both me-
chanical and thermal properties of the samples. 
5.2.1 Thermal properties 
DSC analysis provides information on degradation of the polymer fibers, because de-
crease in molecular weight is often related to decrease in glass transition and melting 
temperatures. Unexpectedly, the melting temperature was increased by 2 °C during the 
36-week incubation period. In previous studies with irradiated PLDLA 96/4 fibers Ellä et 
al. reported a decrease of 0.6 °C after 20 weeks [57] and Lyyra a decrease of 0.5 °C after 
36 weeks [58]. As is illustrated in Figure 39, the overall changes in the melting tempera-
ture were very small. The results from DSC analysis can be found in Appendix C. 
 
Figure 39. Glass transition and melting temperatures of irradiated PLDLA 
96/4 fibers undergoing hydrolytic degradation. (n = 2) 
The glass transition temperatures slightly decreased during the 36-week incubation pe-
riod, by 0.9 °C (Figure 39). This corresponds well to results from previous studies. Ellä 
et al. reported a decrease of 1.6 °C after 20 weeks [57] and Lyyra a decrease of 4.9 °C 
after 36 weeks [58]. It takes less energy for the materials to change from glassy to rubbery 
state when the molecular weight of the polymer has decreased. In this regard, the material 
behaved as expected. 
The crystallinity of the PLDLA 96/4 fibers increased from 42.4 % to 44.1 % during the 
36-week incubation (Figure 40). The value peaked at 24 weeks reaching 46.0 % if the 
results from week 28 are dismissed as unreliable. At week 28, measurements from both 
parallel samples differed a great amount from other measurements. Ellä et al. and Lyyra 
both reported increased crystallinities in their studies. Ellä et al. 8 % after 20 weeks [57] 
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and Lyyra 1.9 % after 36 weeks [58]. The initial crystallinity was 37 % in the first men-
tioned and 41.0 % in the latter. 
 
Figure 40. Crystallinity of irradiated PLDLA 96/4 fibers undergoing hydro-
lytic degradation. (n = 2) 
Thermograms in Figures 41 and 42 are provided to give more information on changes in 
thermal properties of the fibers during the hydrolytic degradation study. For both Figures, 
samples with typical thermogram shapes were chosen from weeks 0, 16 and 36. The melt-
ing endotherms in Figure 41 at approximately 155 °C do not change significantly in size 
or shape during the study. The peaks remain large and narrow. This corresponds well to 
the small changes in the crystallinity of the fibers. A greater increase in crystallinity would 
result in melting peaks covering a larger surface area. Thermograms from the first heating 
cycle were used to measure all melting temperatures and crystallinities of the samples. 
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Figure 41. DSC thermograms from the first heating cycle of irradiated PLDLA 
96/4 fibers undergoing hydrolytic degradation. 
Thermograms from the second heating cycle were used to measure the glass transition 
temperatures of the fibers. Figure 42 shows the shapes of the curves at glass transition to 
get slightly steeper during the degradation. The size of the peaks also decreases, but both 
changes are very small. Between 100 °C and 165 °C cold crystallization exotherm can be 
observed, which is followed by melting peak indicating melting of these crystals. The 
cooling rate during the analysis is too high to allow crystals to be formed after the first 
heating cycle. The amorphous structure organizes into crystal structure upon heating dur-
ing the second cycle and melts subsequently after more energy is applied. 
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Figure 42. DSC thermograms from the second heating cycle of irradiated 
PLDLA 96/4 fibers undergoing hydrolytic degradation. 
The results from DSC analysis are similar to results from previous studies. The slightly 
upwards trend of melting temperatures during degradation is not a concern, as the differ-
ence in comparison to the referenced studies is in range of a few degrees at most. Valuable 
information on crystallinity was obtained to supplement the results from tensile testing 
presented in the following subsection. 
5.2.2  Mechanical properties 
Tensile testing method was used to measure tensile strength and strain at maximum load 
of the PLDLA 96/4 fibers at each time point of the hydrolytic degradation study. Relative 
ultimate tensile strength (UTS) is presented in Figure 43 and relative strain at maximum 
load in Figure 44. The absolute values of the mechanical properties can be found in Ap-
pendix D.  
The tensile strength is a valuable tool for material performance evaluation as it is related 
to the cross-sectional area of the sample. During the 36-week hydrolysis study, the aver-
age tensile strength decreased to 67 % (201 MPa) of the initial value (299 MPa). Hydro-
lytic scission of the polymer chains leads to decrease in molecular weight of the polymer, 
which lowers the mechanical properties. The strength decreased rapidly 20 % during the 
first 4 weeks of the study. After 20 weeks, the fibers had retained 79 % (235 MPa) of their 
initial strength, which is higher than 65 % and 66 % reported previously by Ellä et al. [57] 
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and Lyyra [58]. The results from these studies are not directly comparable, because of 
differences in processing parameters and raw material properties such as initial molecular 
weight. Paakinaho et al. have shown the processing temperatures to affect the lactide 
monomer content of melt-processed PLDLA 96/4. The presence of lactide monomers is 
a result of thermal degradation of polylactide during extrusion. Degradation rate of the 
polymer increases with the monomer concentration. [59] The fibers were intact and easy 
to handle after 36 weeks. The study gives an insight to degradation rate of the fibers, but 
could still have had continued. In the study by Lyyra, the irradiated fibers did not with-
stand handling after 28 weeks of hydrolytic degradation as the tensile strength had de-
creased to 82 % of the initial value [58]. 
 
Figure 43. Ultimate tensile strength retention of irradiated PLDLA 96/4 fibers 
undergoing hydrolytic degradation. (n = 5–6) 
The relative strain results in Figure 44 show the fibers to have a small degree of upward 
trend until week 20, after which the strain values begin to decrease. In the study by Ellä 
et al., a similar trend was seen during the first 20 weeks of hydrolytic degradation [57]. 
Lyyra demonstrated the strain values to remain close to the initial value until 16 weeks 
after which a rapid decrease was observed [58].  After 36 weeks, the average strain value 
had decreased to 91 % of the initial value. The increase of crystallinity observed in the 
DSC analysis decreases the strain values of the fibers. The changes in the strain at maxi-
mum load did not change significantly during the study. This proposes that the study 
could have had continued beyond 36 weeks as was already suggested when discussing 
the tensile strength results. It is necessary notice the large standard deviation values in the 
results, which leads to questioning the reliability of the results. 
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Figure 44. Changes in strain at maximum load of irradiated PLDLA 96/4 fi-
bers undergoing hydrolytic degradation. (n = 5–6) 
Though the samples were handled with a careful manner, the results can be affected by 
user- and device-related errors. The first mentioned includes not having the sample fibers 
at uniform tension between the clamps or having the samples not applied precisely in the 
tensile testing direction. The fiber bundles had entangled to various degrees in the test 
tubes. It is possible to cause mechanical stress to the fibers when separating the bundles 
for testing. Slipping of the fiber between the clamps may occur during testing, which is 
an example of a device-related error. Because of not double checking the test program 
settings before each test, in the last three time points an incorrect crosshead speed value 
10 000 mm/s was used. Lower speed may lead to increased strain values and decreased 
strength values [60]. 
5.3 In vitro cell culture studies 
The viability and distribution of hUCs and hFFs on PLDLA 96/4 textile scaffolds was 
studied using Live/Dead and crystal violet staining methods. In Live/Dead images live 
cells are shown in green and dead cells in red. Images taken from crystal violet stained 
cells show live cells in violet. Throughout the experiment, a large amount of live cells 
was seen spread on bottoms of the wells. Both sides of the scaffolds were inspected at 
each time point and images taken from the top surfaces where the cells were initially 
seeded. 
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5.3.1 Cell viability and distribution in vitro 
Figure 45 shows that all PLDLA 96/4 textile scaffold types supported hUC viability. On 
day 1, very few cells were found attached to the scaffolds. On day 7, the amount of at-
tached cells had significantly increased on all scaffold types. Only the knitted scaffolds 
did not experience clear increase in the amount of attached hUCs between days 7 and 14. 
Red glow and small dots were present in some images, such as woven scaffold on day 14 
in Figure 45. One confirmed dead cell was found on a braid on day 1.  
 
Figure 45. Viability and distribution analysis of hUCs on PLDLA 96/4 textile 
scaffolds using fluorescent staining method. Scale bars 500 µm. 
On the top surfaces of the braided and knitted scaffolds, the hUCs seem to prefer the sides 
of the fibers pointing down inside the scaffold. On the woven scaffolds the cells have 
attached to all visible sides of the fibers. Because of the large pores in the knitted scaf-
folds, cells can be seen growing inside the scaffolds on days 7 and 14. On top surfaces 
braided and knitted scaffolds, hUCs do not prefer any specific sites. On woven scaffolds 
more cells are attached to the weft yarns than to the warp yarns as can be best seen in the 
image taken on day 14 (Figure 45). The knitted scaffolds had the smallest number of cells 
attached to the fibers after 2 weeks. Having significantly larger pores than the other scaf-
folds seems to be a disadvantage.   
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The PLDLA 96/4 textile scaffolds supported viability of hFFs as can be seen in the fluo-
rescent images in Figure 46. On the first day, the shape of the attached cells is mostly 
round on all scaffold types. The area covered by cells increases significantly from day 1 
to day 7 for all scaffold types and the cells take a longer shape. On day 14, the cells almost 
completely covered the top surfaces of the braided and woven scaffolds, while the large 
pores of the knitted structures remain mostly cell-free. Up to approximately 200 µm long 
fibroblast bridges were formed in braids and knits. Only four dead cells were found. On 
braided scaffolds at days 1 and 14 and on a woven scaffold at day 7. 
 
Figure 46. Viability and distribution analysis of hFFs on PLDLA 96/4 textile 
scaffolds using fluorescent staining method. Scale bars 500 µm. 
On day 1, the hFFs did not prefer any specific sites on any of the scaffold types. One 
week after seeding, there were more cells in cavities between the fibers of braided and 
woven structures than on the outermost surface of the fibers. On day 14, this can be still 
seen in the woven scaffold in Figure 46 where the highest ridges of the weft yarns are 
cell-free while the rest of the scaffolds surface is covered in cells. After 2 weeks of cell 
culture, the braided and knitted scaffolds were almost completely covered in cells and no 
preference of site for the cells to attach could be seen. 
In the crystal violet staining images (Figure 47), hUCs are shown as dark dots on the top 
surfaces of the scaffolds. A small amount of cells has attached to all scaffold types. In 
braided and woven scaffolds, the cells did not prefer any sites. The knitted scaffolds had 
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slightly more cells attached to the long straight parts of the loops than to other parts. The 
same observation was made from images taken from one layer below the top through the 
loops. 
The hFFs in Figure 47 can be seen as elongated dark areas often spreading over up to 
several fibers, as best seen in images taken of knitted and woven scaffolds. A small 
amount of cells was found attached to all scaffold types. No clear preference over attach-
ment site was seen in any of the scaffold types. The dark background and the shadows 
make observing hFFs on the scaffolds challenging. 
 
Figure 47. Viability and distribution analysis of hUCs and hFFs on PLDLA    
96/4 textile scaffolds using crystal violet staining method. Scale bars 500 µm. 
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Fluorescence and crystal violet staining viability studies showed that PLDLA 96/4 scaf-
folds supported cell attachment for both hUCs and hFFs. Only a few dead cells were 
found in the fluorescence images throughout the study. There were no strong implications 
of the cells preferring any textile type or type-specific site for attachment. The number of 
attached cells was affected more by the pore sizes. The hUCs did not cover any pores and 
hFFs did not cover the largest pores in the range of hundreds of micrometers. Both cell 
types, especially hFFs, preferred pits to ridges. From the two staining techniques used in 
this experiment, the fluorescence imaging gave a better insight on cell viability and dis-
tribution as the images were more suitable for visual analysis. From the crystal violet 
staining images, it was difficult to separate cells from other dark areas. 
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6. CONCLUSIONS 
The aim of this thesis was to compare cell distribution and viability on textile scaffolds 
for tissue engineering applications. For the cell culture experiment with hFFs and hUCs, 
PLDLA 96/4 fibers were manufactured using melt spinning method. The fibers were used 
as 4- or 8-ply bundles and processed into three types of textile scaffolds: (i) braided, (ii) 
knitted and (iii) woven. The multi-layered scaffolds were heat treated under compression 
to have similar thicknesses and sterilized with gamma irradiation. 
A 36-week in vitro hydrolytic degradation study was conducted for the fibers. DSC was 
used to observe changes in thermal properties and crystallinity. Tensile testing method 
was used to evaluate mechanical properties during degradation. A slight increase in melt-
ing temperature was observed, which was not expected based on previous studies. The 
glass transition temperature decreased, similar to previous studies with PLDLA 96/4 fi-
bers. A few percent increase in crystallinity was seen during the degradation study. De-
creasing molecular weight increases chain mobility allowing crystals to be formed more 
easily. Tensile testing experiment showed the ultimate tensile strength of the fibers to 
decrease during degradation. The changes were rapid during the first three weeks, fol-
lowed by an overall decreasing trend. The lowest strength values were obtained at the 
final 36-week time point as expected. Strain at maximum load decreased as well. The 
changes in mechanical properties are related to the increased crystallinity, which makes 
the fibers more brittle. Determining molecular weight of the samples at each time point 
would have been desirable. The molecular weights of polymer chains affect both mechan-
ical and thermal properties of the samples.  
To ensure predictable behavior of the scaffolds during the cell culture experiment, the 
sterilized scaffolds were tested for dimensional stability after heat treatment and in cell 
culture medium. Both tests showed the scaffolds to retain their shape and dimensions 
adequately.  
The cell culture experiment demonstrated good cell viability for both cell types on all 
scaffold types. Based on visual inspection from microscopic images, the number of hUCs 
increased throughout the 2-week test period on braided and woven scaffolds. On knitted 
scaffolds, the largest number was reached after 1 week of incubation. At the last time 
point, the knitted scaffolds had the least attached cells. This is due to much larger pores 
than the other scaffold types had. The number of hFFs increased on all scaffold types 
during the test period. On day 7, the cells preferred sites between the fibers. On day 14, 
the fibers on braided and knitted samples were fully covered with cells. Only the pores, 
especially the largest on knitted scaffolds, remained cell free. On woven scaffolds, only 
the highest ridges of weft yarn fibers remained uncovered. As a conclusion, both cell 
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types preferred structures with small pores or no visible pores. In addition, the cells pre-
ferred to attach to pits instead of ridges. This was the most evident with hFFs. 
The experiments conducted for this thesis demonstrated that PLDLA 96/4 fiber bundles 
can be processed into biodegradable braided, knitted and woven textile scaffolds. These 
structures support viability of cells in vitro. The number of attached cells was the largest 
in braided and woven structures that had significantly smaller pores in comparison to 
knitted scaffolds. 
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APPENDIX B: FIBER MATERIALS USED IN TE TEXTILES 
Material Number of research articles 
PGA 36 
Silk 36 
PLGA 28 
PLA 25 
PCL 14 
PET 13 
Hyaluronic acid 11 
P(LA-CL) 10 
Chitosan 8 
PHAs 4 
PP 4 
PGA+PLLA BLEND 3 
Chitosan + Hyaluronic acid BLEND 2 
Collagen 2 
PA 2 
PDS 2 
PTFE 2 
Alginate 1 
BioGlass 1 
Carbon nanotube 1 
Cellulose 1 
Chitosan + PBS BLEND 1 
Chitosan + PBTA BLEND 1 
P(DTD DD) 1 
PBS 1 
PE 1 
PEA 1 
PEEK 1 
PLLA + PCL BLEND 1 
PS 1 
PVDF 1 
Starch + PCL BLEND 1 
Titanium 1 
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APPENDIX C: DSC RESULTS 
Hydrolysis week Dry/Wet Tm (°C) S.D. Tg (°C) S.D. Xc (%) S.D. n 
0 Dry 154.5 0.56 60.2 0.10 42.4 0.19 2 
1 Wet 155.1 0.40 59.9 0.02 43.0 0.52 2 
8 Wet 154.7 0.18 60.0 0.00 44.6 0.19 2 
16 Wet 155.3 0.36 59.7 0.05 45.7 0.38 2 
24 Wet 155.6 0.36 59.4 0.02 46.0 0.98 2 
28 Wet 156.0 0.07 59.6 0.17 49.5 17.71 2 
36 Wet 156.5 0.28 59.3 0.01 44.1 0.13 2 
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APPENDIX D: TENSILE TESTING RESULTS 
 
Hydrolysis 
week 
Dry/Wet 
Stress at 
max. Load 
(MPa) 
S.D. 
Load at 
max. Load 
(N) 
S.D. 
Strain at 
max. Load 
(%) 
S.D. n 
0 Dry 308.6 29.9 2.0 0.1 79.8 11.4 6 
0 Wet 298.5 45.1 2.0 0.1 81.3 7.2 6 
1 Wet 280.2 24.2 1.9 0.1 76.6 12.2 6 
2 Wet 257.3 27.3 1.9 0.2 78.7 17.1 6 
3 Wet 237.5 25.7 1.8 0.2 85.0 7.7 6 
4 Wet 257.0 6.6 1.9 0.1 80.8 4.4 6 
8 Wet 272.2 21.1 2.0 0.2 77.3 15.2 6 
12 Wet 213.6 10.3 1.5 0.1 85.7 8.0 6 
16 Wet 240.0 13.5 1.7 0.1 78.2 7.8 6 
20 Wet 235.9 13.7 1.7 0.1 86.6 9.5 6 
24 Wet 240.6 12.7 1.7 0.1 82.7 11.9 6 
28 Wet 227.7 17.9 1.6 0.1 78.3 10.2 5 
32 Wet 213.9 10.5 1.5 0.1 78.6 9.4 6 
36 Wet 201.2 16.1 1.5 0.1 74.2 8.9 6 
 
